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ABSTRACT 
CONSERVED NON-CODING ELEMENT DERIVED REGULATION OF THE MEIS2A 
HOMEOBOX GENE DURING EMBRYONIC DEVELOPMENT 
Cody Evan Barrett, B.S., University of North Carolina at Chapel Hill 
M.S., Appalachian State University 
Chairperson: Dr. Ted Zerucha 
Homologues of the Meis genes family have been identified in all animals studied.  
Meis genes are a member of the TALE (three amino acid loop extension) superclass of 
atypical homeobox genes, whose products are characterized by an additional three amino 
acids between helix 1 and helix 2 of their homeodomain.  The vertebrate homeobox-
containing Meis gene family includes at least four members that are expressed in spatially 
and temporally conserved fashion throughout development in all vertebrates examined thus 
far.  Products of the Meis genes appear to function as cofactors, interacting with both other 
transcription factors and DNA to assist in the regulation of transcription.  Most importantly, 
they appear to work with the Hox proteins as well as other various homeobox genes’ 
products including the Pbx proteins.  At this time, little is known about the regulation of the 
Meis genes.  Using phylogenetic footprinting to search for regulatory elements in association 
with the Meis family of homeobox-containing genes, we identified a highly conserved 
element located downstream of the Meis2 gene that we have called Meis2 Downstream 
Element 1 (m2de1).  This putative enhancer is conserved in sequence and position across the 
genomes of all vertebrates examined, including human, mouse, chicken, and zebrafish.  
v 
Furthermore, the m2de1 element contains several putative transcription factor binding sites 
for proteins that could be regulating Meis2 expression.  In this study, we have demonstrated 
the ability of m2de1 to drive reporter gene expression through microinjection derived 
transgenic analysis.  Reporter gene expression was observed in the developing brain of 
zebrafish embryos in a manner consistent with endogenous Meis2 expression, potentially 
implicating the m2de1 element with cis-regulatory function. 
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This thesis manuscript and the references, figures, and tables within were arranged in 
accordance with the instructions detailed for manuscript submission to the peer-reviewed 
journal Developmental Biology, the official journal of the Society for Developmental 
Biology, published by Elsevier. 
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INTRODUCTION 
The process of fertilization initiates embryonic development which then proceeds 
through a series of complex, yet coordinated, cellular interactions, resulting in rapid growth, 
cell division, and ultimately cellular specialization.  The underlying commonality behind all 
organismal development is deoxyribonucleic acid, or DNA.  In a process known as 
transcription, the genetic information stored in DNA is copied into an intermediate structure 
known as ribonucleic acid, or RNA.  The mRNA is then decoded into protein in a procedure 
called translation.  These processes occur at all times in cells for homeostasis and repair and 
are especially important during development.  To insure that these genetic processes proceed 
in a correct and efficient manner, a series of regulatory steps exist in the gene expression 
mechanisms of eukaryotes and prokaryotes.  This regulation includes:  transcriptional 
control, mRNA processing, mRNA transport control, translation control, and protein control 
(Alberts, 2008).  All these steps taken together help to insure that gene expression, and 
therefore, embryonic development proceeds properly, resulting in a final, functional adult 
organism.   
The first level of gene regulation is that of transcriptional control.  Arguably the most 
important and diverse level of regulation, transcriptional control consists of a series of steps 
working together to regulate when and how often a gene is transcribed (Alberts, 2008; 
Griffiths, 2000; Orphanides et al., 1996; Zawel et al., 1995).  Transcription in eukaryotes is a 
complex process involving numerous proteins and their subsequent interactions with each 
other as well as the DNA to be utilized (Orphanides et al., 1996; Zawel et al., 1995).  The 
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process of transcription depends on the General Transcription Factors (GTFs); called general 
because while other transcriptional proteins necessary may vary from gene to gene, the GTFs 
must be present for any eukaryotic gene expression event (Alberts, 2008; Orphanides et al., 
1996).  The GTFs work to recruit RNA Polymerase II (RNAPII) to the promoter, help to pull 
apart the two strands of DNA to allow RNAPII access to the DNA template, and to release 
the RNAPII from the promoter once transcription has begun (Orphanides et al., 1996).  The 
first GTF to bind to the DNA is Transcription Factor IID (TFIID) (Nikolov et al., 1996; 
Orphanides et al., 1996; Sawadogo and Sentenac, 1990).  One of TFIID’s numerous protein 
subunits is TATA Binding Protein (TBP), which binds specifically to the DNA sequence 
known as the TATA Box (Li et al., 1999; Nikolov et al., 1996; Orphanides et al., 1996).  The 
TATA Box, although not present in all eukaryotic gene promoters, is one of the most 
significant DNA sequences utilized by transcriptional proteins to begin transcription (Mathis 
and Chambon, 1981).  Usually located 25 base pairs upstream of the transcriptional start site, 
it is believed that the TATA site also facilitates subsequent DNA unwinding due to the 
abundance of the weaker bonded adenines and thymines in these areas (Juo et al., 1996; Kim 
et al., 1993; Nakatani et al., 1990).  Once TFIID has bound to the promoter through its TBP 
subunit, additional GTFs such as Transcription Factor IIB (TFIIB), Transcription Factor IIE 
(TFIIE), and Transcription Factor IIH (TFIIH), as well as RNAPII are recruited to the site 
and bind to each other forming what is called the transcription initiation complex 
(Buratowski et al., 1989; Roeder, 1991).  The GTF TFIIH has a functional helicase that uses 
ATP to unwind nucleosomes and dislodge histones resulting in the actual unwinding of the 
DNA helix (Drapkin et al., 1994; Svejstrup et al., 1996).  RNAPII, previously recruited to the 
promoter site, is phosphorylated by a protein kinase subunit of TFIIH, and is released from 
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the transcription initiation complex to begin elongation (Akoulitchev et al., 1995; Svejstrup 
et al., 1996).  In elongation, the gene of interest is copied into a complimentary, antiparallel 
mRNA strand through the action of the RNAPII.  One of the most important facets in 
association with the regulation of gene expression is the inherent ability of RNAPII to 
proofread its own mistakes in mRNA production (Sydow and Cramer, 2009; Thomas et al., 
1998).  Such a procedure insures that the mRNA is true to its DNA parent strand and that 
subsequent expression steps produce a viable, functional protein.  Another important gene 
regulation step associated with the RNAPII is that if for some reason it becomes dislodged 
from the DNA template, it cannot rejoin where it left off (O’Shea-Greenfield and Smale, 
1992; Pankotai and Soutoglou, 2013).  In fact, the RNAPII must start all over from the 
promoter (O’Shea-Greenfield and Smale, 1992).  This safeguard makes it impossible for the 
RNAPII to produce an abundance of mRNA fragments; it must transcribe the whole DNA 
sequence.  Upon completion of transcription, the single stranded mRNA that results serves to 
deliver the genomic information to the protein producing structures located in the cell’s 
cytosol.   
Actual eukaryotic transcription events require the implementation of many more 
proteins and sequences found on the template DNA aside from the promoter and the GTFs to 
insure successful production of mRNA (Davidson, 2006; Frith et al., 2001).  These additional 
parameters serve to guard against unnecessary and unwanted mRNA production, making sure 
that transcription occurs only when spatially and temporally necessary (Bustos et al., 1991; 
Fisher et al., 2006; Kwan et al., 2001).  Cis-regulatory elements are regions of DNA that 
regulate the expression of a gene located on the same molecule of DNA as itself and have 
been found to be especially clustered near genes important for embryonic development 
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(Alberts, 2008; Kikuta et al., 2007b; Navratilova and Becker, 2009).  Unlike the promoter 
regions which are always found upstream of their associated gene, cis-regulatory elements 
can be found upstream, downstream, within introns of genes, or up to 15000 base pairs away 
from the initiation complex (Davidson, 2006; Dutton et al., 2008; Echelard et al., 1994; 
Kikuta et al., 2007b; Valverde-Garduno et al., 2004).  These cis-regulatory elements are not 
expressed (Kikuta et al., 2007b).  Instead, they are highly conserved sequences ranging in 
size but usually under 1000 nucleotides long that serve as binding sites for additional 
transcriptional regulatory proteins (Woolfe et al., 2005).  Cis-regulatory elements show an 
extreme amount of sequence conservation due to their importance in gene regulation, and 
consequent resistance to evolutionary strain (Engstrom et al., 2007; Navratilova and Becker, 
2009).  Because they are highly conserved, phylogenetic footprinting can be used to identify 
and locate potential cis-regulatory elements (Fisher et al., 2006; Kikuta et al., 2007a; Kikuta 
et al., 2007b; Woolfe et al., 2005).  The process of phylogenetic footprinting involves the 
comparison of specific regions of DNA believed to contain Highly Conserved Noncoding 
Elements (HCNEs) across multiple species (Navratilova and Becker, 2009; Woolfe et al., 
2005).  Previous research has shown that HCNEs often have cis-regulatory function, 
although such assumptions must still be experimentally tested (Fisher et al., 2006; Woolfe et 
al., 2005).    
Currently, it is not known if new cis-regulatory elements can evolve from random 
sequences (Ludwig, 2002).  In fact, it is believed that the existing cis-regulatory elements are 
modified, resulting in elements with novel function (Blader et al., 2004; Ludwig, 2002).  
Exactly how cis-regulatory elements do so is currently unknown, but many promising 
hypotheses exist.  The first of these hypotheses states that the new cis-regulatory sequences 
 
5 
 
could be formed by rearrangement and sequence modification; specifically the addition or 
subtraction of protein binding sequences from existing elements, so that they gain a new 
function (Blader et al., 2004; Ludwig, 2002).  Another reasonable hypothesis proposes that a 
previously existing element simply develops an association with a previously unassociated 
gene resulting in a new regulatory function (Blader et al., 2004; Ludwig, 2002). 
As mentioned previously every eukaryotic transcriptional event utilizes the GTFs as 
well as RNAPII meaning differential gene expression and diversity cannot stem from such 
properties.  Instead, it is believed that the cis-regulatory elements are the factors that help 
differentiate when and where transcription of a certain gene occurs (Navratilova and Becker, 
2009).  Each gene has its own subset of specific cis-regulatory elements (Navratilova and 
Becker, 2009; Tumpel et al., 2006).  Although conserved in their sequences, the compliment 
of cis-regulatory elements each gene employs varies from gene to gene, and only when those 
cis-regulatory elements are bound by  their transcriptional proteins can transcription of that 
gene occur (Kikuta et al., 2007b; Navratilova and Becker, 2009; Tumpel et al., 2006).  Even 
though each gene has its own specific subset of cis-regulatory elements, it appears as if the 
cis-regulatory elements are not relegated to act upon just one specific gene, but can work to 
direct the expression of several different genes, thus a level of cis-regulatory element sharing 
is believed to be rather common (Gould et al., 1997; Zerucha et al., 2000).  The proteins 
bound to the cis-regulatory sequences work together to regulate the expression of a gene in 
numerous ways, but one of the most unique and influential is that they can cause the DNA 
helix to loop back upon itself, bringing the bound proteins into contact with the previously 
described transcription initiation complex (Gibcus and Dekker, 2013; Tolhuis et al., 2002).  
Thus, they can directly interact with the GTFs, other cis-regulatory bound proteins, or even 
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the RNAPII, directing the general machinery to proceed with transcription (Calo and 
Wysocka, 2013).   
Owing to these numerous characteristics, cis-regulatory elements have been 
implemented in helping to drive the important developmental processes of differentiation, 
morphological diversification, and body plan formation ( Duboule, 1998; Gompel et al., 
2005; Pearson et al., 2005; Whiting et al., 1991).  As is the case for most genes, most 
developmentally important genes are under the influence of a variety of multiple cis-
regulatory elements as well (Woolfe et al., 2005).  The method in which cis-regulatory 
elements cause differentiation and diversification stems from the differential utilization of the 
elements (Gompel et al., 2005).  The spatiotemporal expression patterns of a single gene can 
be driven in vastly different ways depending upon which cis-regulatory elements in that 
gene’s compliment of cis-regulatory elements are actively bound by transcriptional proteins 
(Blader et al., 2004; Gompel et al., 2005; Navratilova et al., 2010; Tumpel et al., 2006).  
Thus, cis-regulatory elements can provide a vast source of expression differentiation and 
organization depending on the subset of elements a particular gene utilizes in any given 
transcription event (Blader et al., 2004; Gompel et al., 2005; Navratilova et al., 2010; Tumpel 
et al., 2006).  Cis-regulatory elements are also thought to play important roles in evolution as 
diversification and differential gene expression can be altered through the random, slight 
mutation of their DNA sequences (Stone and Wray, 2001; Wray, 2007).  Such mutations 
could cause novel transcription factor binding resulting in differential gene expression (Stone 
and Wray, 2001; Wray, 2007).  Prior to the advent of phylogenetic studies, it was believed 
that species were differentiated from each other solely based on the distinctiveness of their 
genes (Carroll et al., 2008).  Through the influx of sequencing and advanced phylogenetics, it 
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is commonly known now that many genes are conserved across widely divergent organisms, 
that evolutionary pressures have been unable to act upon said genes, and therefore 
organismal differentiation and body plan morphologies must be the result of discrepancies 
and variation in gene regulation (Castillo-Davis et al., 2004; Davidson, 2001).  As stated 
previously, cis-regulatory elements can in fact drive such variation and therefore could be a 
driving force behind organismal evolution and branching (Castillo-Davis et al., 2004; 
Davidson, 2001).          
 There exist three different types of cis-regulatory elements:  enhancers, silencers, and 
insulators (Bell et al., 2001; Woolfe et al., 2005).  Enhancers theoretically work to increase 
the probability of transcriptional events, driving expression of a gene in an efficient, yet 
regulated fashion (Fiering et al., 2000; Walters et al., 1995).  As with all cis-regulatory 
elements, the transcriptional proteins that bind enhancers, sometimes referred to as activator 
proteins, subsequently interact and influence other chromatin bound proteins or even the 
actual protein complex assembled at the promoter to commence transcription (Popham et al., 
1989; Szutorisz et al., 2005).  The next classification of cis-regulatory elements, silencers, is 
the antithesis of enhancer elements, working to suppress gene expression (Alberts, 2008; 
Brand et al., 1985; Clark and Docherty, 1993).  Silencers are bound by suppressor proteins, 
which like activator proteins interact with a various assortment of transcriptional proteins, 
but unlike activators work to decrease or halt gene expression altogether (Clark and 
Docherty, 1993).  The last of the three cis-regulatory elements are insulators.  Insulators are 
regions of DNA located between enhancer elements and the promoters under their influence 
or between silencers and the promoters they direct (Gerasimova and Corces, 2001).  
Insulators are important in areas where two genes having vastly different roles and 
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transcriptional expression patterns are located adjacent to one another (Gerasimova and 
Corces, 2001).  In other genetic regions, the insulators serve to inhibit the enhancers and 
silencers in association with one gene from interfering with the expression of the adjacent 
gene (Burgess-Beusse et al., 2002; Geyer, 1997).  
Enhancers and silencers can also influence the regulation of gene expression events at 
the transcriptional level by altering the composition and subsequent conformation of the 
DNA itself.  DNA in eukaryotes is most commonly found in the form of chromatin, which 
consists of the actual DNA molecule as well as associated proteins known as histones 
working to protect, package, and strengthen the DNA (Alberts, 2008; Bonner et al., 1968).  
The interaction of the DNA and its histone proteins makes it physically difficult for the 
transcriptional machinery to bind to and transcribe genes (Grunstein, 1997; Rombauts et al., 
2003; Struhl, 1999).  Often times, the composition of the DNA can prevent enhancers and 
silencers from carrying out their roles during transcription (Lee et al., 1993; Rombauts et al., 
2003).  DNA methylation, which is the addition of methyl groups to the cytosine nucleotides 
within a cis-regulatory element, can prevent proteins from binding to these sequences, 
inhibiting their influence (Razin and Riggs, 1980; Rombauts et al., 2003; Weber et al., 2007).  
However, the activators and suppressors that bind to functional enhancers and silencers can 
regulate the expression of a gene by recruiting enzymes that alter the degree of packing a 
gene and its histones employ (Struhl, 1999).  Generally, the recruited enzymes will work to 
add or remove acetyl groups from the histones, resulting in looser or tighter chromatin 
respectively (Struhl, 1999).  Some suppressor proteins have even been found to successfully 
recruit methylation and deacetylation enzymes to the region of DNA undergoing potential 
transcription in an effort to prevent the RNAPII from gaining access to the DNA strands, 
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halting gene expression, while some activators have been shown to do the opposite (Struhl, 
1999). 
Therefore, it is apparent that transcriptional control is a very powerful and diverse 
realm through which gene expression is controlled and regulated.  The utilization of 
transcriptional control, most notably the actions of cis-regulatory elements, is important in 
the process of embryonic development; an extremely complex procedure that involves strict 
adherence to regulated progression.  As mentioned previously, developing embryos utilize 
DNA as a blueprint to direct processes that increase the number of cells present, differentiate 
the exponentially produced cells, and make sure that the functioning of those cells is 
regulated in an organized manner (Wolpert, 2007).  During these processes, body plan and 
specific morphological characteristics begin to develop as well, facilitated by cell-cell 
interactions (Wolpert, 2007).  Crucial to such developmental progression is the formation of 
the body axes so that the anterior of the embryo is differentiated from the posterior 
(anterior/posterior axis), the right from the left (right/left axis), and the back from the 
underside (dorsal/ventral axis) (Wolpert, 2007).  Such axes formation makes it possible for 
the later steps of gastrulation, neurulation, and organogenesis to occur in an acceptable 
fashion (Wolpert, 2007).  The formation of these axes and development overall is often 
associated with a specific set of genes known as the homeobox genes.   
Homeobox genes were discovered via studies of Drosophila melanogaster that 
displayed homeotic mutations, where one body segment has the identity of another body 
segment instead of its own (Morata and Lawrence, 1977; Wolpert, 2007).  Eventually, it was 
determined that such malformations are the result of mutations to a certain set of genes, and 
that those genes play major roles in axis formation and subsequent segment specification 
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(Wolpert, 2007).  Extremely similar genes were subsequently found in numerous other 
organisms.  These genes, eventually grouped together and named Homeobox genes, all 
contain a highly conserved 180 base pair sequence known as the homeobox that codes for a 
well conserved 60 amino acid protein domain named the homeodomain (Gehring, 1987; 
Gehring, 1993; McGinnis et al., 1984).  The homeodomain consists of a helix-loop-helix 
protein domain commonly seen in other proteins that have the capability of binding DNA 
(Otting et al., 1988).       
Of special importance for the formation and maintenance of the anterior/posterior 
(A/P) axis are the Hox genes (Lemons and McGinnis, 2006).  The Hox genes are a subset of 
the Homeobox genes and have been found in all animal species tested so far (Holland and 
Garcia-Fernandez, 1996; Lemons and McGinnis, 2006).  Although they are important in the 
development of organisms displaying a distinct A/P axis, Hox genes have been found in 
Cnidarians, but it is believed that they have no apparent relative in plants, protozoa, or 
sponges (Balavoine et al., 2002; Lemons and McGinnis, 2006).  The Hox genes are normally 
found grouped as clusters in the same arrangement in relation to each other on the 
chromosome, and this particular organization is utilized to help regulate them spatially and 
temporally during development (Lemons and McGinnis, 2006).  The Hox genes positioned 
more toward the 3’ end of the grouping are expressed more towards anterior regions and 
earlier on in development, while the Hox genes located nearer the 5’ end are expressed in the 
embryos posterior areas and at later times during development (Amores et al., 1998; 
Duboule, 1998; McGinnis and Krumlauf, 1992).  This unique function associated with the 
Hox genes is called colinearity (Amores et al., 1998; Duboule, 1998; McGinnis and 
Krumlauf, 1992; Prince et al., 1998). 
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Although most metazoans possess Hox gene orthologs and these genes are normally 
found in the same position in relation to each other in all species, the number of clusters 
present varies from species to species (Amores et al., 1998).  This consequently leads to a 
wide variation in total Hox gene number for each species (Amores et al., 1998; Lemons and 
McGinnis, 2006).  In most invertebrates, there exists only one cluster of the Hox genes with 
varying numbers of actual Hox genes, although eight are usually attributed to insects 
(Amores et al., 1998; Holland and Garcia-Fernandez, 1996).  In contrast, most tetrapod 
vertebrates have been found to contain four Hox gene clusters with as many as 13 genes 
existing in a cluster (Greer et al., 2000; Lemons and McGinnis, 2006).  These extra clusters 
have subsequently been designated as HoxA, HoxB, HoxC, and HoxD, and each individual 
gene within those clusters has been assigned a paralog number for organizational purposes 
(Greer et al., 2000; Lemons and McGinnis, 2006).  The number of clusters presented 
previously only serves as a baseline for predicting how many Hox gene clusters actually exist 
in a species, as variations from the norm often times are found.  Some invertebrates have 
experienced a severe degradation in the conservation and organization of their Hox genes, 
although they still technically possess them (Wagner et al., 2003).  With the vertebrates and 
other chordates, these variations are often times the result of whole genome duplication 
events that occurred during their evolutionary history (Amores et al., 1998; Kuraku and 
Meyer, 2009).  In fact, genome duplication was the driving force behind the formation of 
three extra Hox gene clusters found in the tetrapod lineage that are not seen in invertebrate 
genomes (Amores et al., 1998).  Another perfect example of such variation is seen in the 
teleosts, which although vertebrates, possess seven Hox clusters and 49 total Hox genes 
(Amores et al., 1998; Brunet et al., 2006; Prince et al., 1998; Prohaska and Stadler, 2004).  It 
 
12 
 
is believed that the teleost fishes, the lineage which includes zebrafish (Danio rerio), 
underwent an additional teleost specific genome duplication event after the evolutionary 
divergence of ray-finned and lobe-finned fishes, just before teleost expansion, resulting in a 
total of eight Hox gene clusters (Amores et al., 1998; Brunet et al., 2006; Prohaska and 
Stadler, 2004).  Somewhere within that evolutionary history, one of the clusters was lost, 
leaving the seven clusters present today (Brunet et al., 2006; Prohaska and Stadler, 2004).  
Research has shown that the genome duplication events may have coincided with the 
increasing complexity and expansion of various body plans seen during the course of 
evolutionary history (Venkatesh, 2003).  Such duplications would have presented numerous 
new genes and allowed for novel developmental control mechanisms, resulting in increased 
axial diversity (Holland and Garcia-Fernandez, 1996). 
The methodology behind how and why the Hox genes play such a major role in 
embryonic development stems from the fact that as mentioned previously, the homeodomain 
present within their protein structures have the ability to bind DNA (Dorn et al., 1994; 
Gehring, 1993; Gehring et al., 1994).  Therefore, the Hox genes code for transcription factors 
that bind to cis-regulatory elements associated with developmentally important genes, 
helping direct those genes’ regulation and activation (Dorn et al., 1994; Gehring et al., 1994).  
Each Hox protein,  regulated in a highly stringent spatiotemporal manner, serves to direct the 
identity and morphology of those regions in which they are expressed (Moens and Selleri, 
2006).  However, such Hox-DNA binding has been shown to be unspecific and inefficient by 
itself; a major problem considering the implications the Hox genes have concerning the 
developmental processes (Ekker et al., 1994; Moens and Selleri, 2006; Waskiewicz et al., 
2001).  Residue mapping studies concerning the Hox proteins revealed that individual Hox 
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proteins could be distinguished from each other by differences in amino acids away from 
their areas that bind DNA; more specifically in the areas in which they would interact with 
other various proteins (Mann and Affolter, 1998; Sharkey et al., 1997).  Thus, in addition to 
binding DNA at the cis-regulatory sequences, it would appear that the Hox transcription 
factors have the ability to bind other proteins (Mann and Affolter, 1998).  By binding other 
transcriptional proteins, known as cofactors, binding specificity is increased simply by 
increasing the DNA surface area to which proteins are bound, resulting in a much more 
regulated gene transcription event (Mann and Affolter, 1998; Moens and Selleri, 2006). 
Many different groups of cofactors exist, one of them being the Three Amino Acid 
Loop Extension (TALE) class of homeobox genes, named after the presence of an additional 
three amino acids in the region between helix one and helix two of the homeodomain 
(Burglin, 1997).  The TALE class includes, but is not limited to, the MEIS, PBC, KNOX, 
IRO, and recently identified MKX subclasses of genes (Burglin, 1997; Mukherjee and 
Burglin, 2007).  The Meis genes, short for Myeloid Ecotropic Leukemia Virus Integration 
Site, were first identified in murine models when the Myeloid Ecotropic Leukemia Virus 
integrated itself into the previously unidentified Meis gene’s open reading frame (Moskow et 
al., 1995).  Ensuing analysis lead to the discovery of Meis gene paralogs in a wide variety of 
divergent organisms and the summation of such research led ultimately to the categorization 
of the Meis gene family.  In vertebrates, three separate Meis genes were found although it 
appears as if teleosts have a total of four:  Meis1, Meis2, Meis3, and Meis4 (Geerts et al., 
2005; Moskow et al., 1995; Nakamura et al., 1996; Waskiewicz et al., 2001).  A Meis gene 
family ortholog was found in invertebrates as well as evidenced by the homothorax gene in 
the fruit fly, Drosophila melanogaster (Kurant et al., 1998; Pai et al., 1998; Rieckhof et al., 
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1997; Ryoo et al., 1999).  Interestingly, similarities between the Meis genes and Knox genes 
in plants have been found, and all indications are that they diverged from a common ancestor 
(Becker et al., 2002; Burglin, 1997; Burglin, 1998).  The vertebrate genomes examined and 
observed to contain Meis gene orthologs include humans (Geerts et al., 2005; Lawrence et 
al., 1999; Smith et al., 1997; Steelman et al., 1997), chicken Gallus gallus (Coy and Borycki, 
2010; Mercader et al., 2000; Sanchez-Guardado et al., 2011), mouse Mus musculus 
(Bomgardner et al., 2003; Cecconi et al., 1997; Nakamura et al., 1996), and the zebrafish 
Danio rerio (Chong et al., 2009; Sagerstrom et al., 2001; Waskiewicz et al., 2001; Zerucha 
and Prince, 2001;).  To add to the complexity, it appears as if Meis genes have the capability 
to be alternatively spliced as well, which suggests that Meis proteins can have various 
functions (Burglin, 1997; Geerts et al., 2005).      
As stated previously, the Meis proteins act as cofactors, binding to cis-regulatory 
sequences found within DNA as well other various transcriptional proteins.  In order to carry 
out its function, the Meis cofactor has two domains set aside for such roles: the 
homeodomain and the flexible N-terminal domain (Burglin, 1997; Chang et al., 1997; Jacobs 
et al., 1999; Shanmugam et al., 1999).  The homeodomain is the region the Meis cofactor 
utilizes to bind to the actual DNA (Chang et al., 1997).  The Meis homeodomain to DNA 
interaction, like all other TALE class cofactor and DNA interactions, is generally not 
believed to be strong and may vary depending on the proteins bound to other areas of the  
cofactor (Burglin, 1997).  The N-terminal domain, commonly called the Meinox domain, is 
the region which enables and facilitates the binding of a specific transcriptional protein; the 
Pbx cofactor (Berthelsen et al., 1998; Chang et al., 1997; Choe et al., 2002; Jacobs et al., 
1999; Shanmugam et al., 1999).  There exists a third region, known as the C-terminal 
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domain.  This domain is responsible for the Meis paralog functional variation, with binding 
the actual Hox proteins themselves, and in helping to distinguish the Meis cofactors from the 
other similarly related proteins (Burglin, 1997; Huang et al., 2005; Irimia et al., 2011; 
Moskow et al., 1995; Shanmugam et al., 1999; Williams et al., 2005). 
Transcription factor proteins have the ability to interact with a wide variety of 
cofactors in order to increase their binding affinity and specificity when binding DNA as a 
monomer (Chang et al., 1997; Moens and Selleri, 2006; Shanmugam et al., 1999).  The 
transcription factors execute such interactions through the utilization of adjacent DNA-
binding half sites and aforementioned conserved motifs flanking their homeodomain (Chang 
et al., 1996; Chang et al., 1997; Phelan and Featherstone, 1997).  The Hox proteins are no 
exception to these rules.  One of the protein-protein interactions seen associated with Hox 
proteins is the formation of a Hox-Pbx dimer in which the Pbx cofactor uses its C-terminal 
region to interact with the N-terminal region of the Hox protein (Chang et al., 1997; 
Shanmugam et al., 1999).  In fact, the majority of the Hox proteins (Paralogs 1-10) can 
interact with Pbx (Shanmugam et al., 1999; Shen et al., 1997;).  In addition, Hox 
transcription factors can utilize their N-terminal structure to form dimers with the Meis C-
terminal domain as indicated earlier, although such binding is not that common as only Hox 
paralogs 9-13 can act with Meis (Shanmugam et al., 1999; Shen et al., 1997;).  Such dimer 
formation occurs on the adjacent DNA binding half sites with the sequence TGACAG-
TTA(T/C), but can occur in the absence of DNA (Shen et al., 1997).  The Meis cofactor is 
able to form dimers with Pbx cofactors through the interactions of N-terminal ends and a 
DNA bipartite sequence consisting of 5’ Pbx and 3’ Meis half sites (Chang et al., 1997; 
Shanmugam et al., 1999; Waskiewicz et al., 2001).  Co-immunoprecipitation studies have 
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shown that the Meis-Pbx dimers even form in the absence of DNA indicating that the Meis 
protein is the favored binding partner for Pbx (Chang et al., 1997).  Alternatively, Meis will 
bind Pbx in situations where Pbx is bound to DNA and the Meis binding motif is absent, 
further indicating the affinity the two proteins have for one another (Shanmugam et al., 
1999).  The Meis cofactors, similar to the TGIF cofactors, seem to bind the atypical 
TGACAG(G/C)T sequence with the first six nucleotides acting as the binding core (Chang et 
al., 1997; Fujino et al., 2001; Zhang et al., 2006).  This preferred binding site is unlike that 
recognized by Hox and other TALE proteins that favor the sequence TAAT (Popperl and 
Featherstone, 1992).  The Meis-Pbx cofactors form dimers on the sequence TGATTGACAG 
where the 5’ TGAT is the preferred binding sequence for the Pbx protein (Chang et al., 1997; 
Fujino et al., 2001; Huang et al., 2005).  The ability for each protein to bind together as well 
as bind to their complete preferred DNA binding sites indicates that Pbx does not alter the 
binding specificity of Meis which varies from that seen in Pbx-Hox interactions (Chang et 
al., 1997).  Aside from their obvious transcriptional importance, Meis-Pbx dimers have been 
implicated in nuclear localization of cofactors as well (Berthelsen et al., 1999; Rieckhof et 
al., 1997; Saleh et al., 2000; Waskiewicz et al., 2001).   
In addition to the dimers listed above, Meis cofactors have been shown to form 
trimeric complexes with Pbx and Hox proteins (Jacobs et al., 1999; Shanmugam et al., 1999).  
Such complex interactions serve to increase the binding specificity.  The trimeric complex 
consists of a Pbx-Hox dimer with each protein bound to its respective DNA binding site, and 
a Meis cofactor attached to the Pbx as well as its own unique DNA binding site (Chang et al., 
1997; Jacobs et al., 1999; Mann and Affolter, 1998; Shanmugam et al., 1999; Shen et al., 
1999).  These trimeric complexes, like the dimers previously mentioned, have been found 
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formed without the presence of DNA, indicating a potential preference for trimer formation 
when possible (Shanmugam et al., 1999; Shen et al., 1999).  Moreover, the incorporation of 
the Meis cofactor within such a complex has been proven to increase the chances and 
stability of trimer formation and function (Jacobs et al., 1999; Schnabel et al., 2000).             
  As stated previously, there are four members in the Meis gene family.  The first of the 
Meis genes is Meis1 which, at early stages of development, is present in posterior regions of 
the embryo, most notably in the primitive streak, somites, and mesoderm, although no 
expression is present in the anterior regions (Coy and Borycki, 2010; Maeda et al., 2002).  At 
later stages of development, Meis1 expression is found in highly restricted areas within the 
midbrain, hindbrain, and the developing eye and the retina, but can still be found in posterior 
regions, most notably in the lateral mesoderm, intermediate mesoderm, and neural tube 
(Bessa et al., 2008; Coy and Borycki, 2010; Maeda et al., 2002; Waskiewicz et al., 2001).  
Meis1 expression is also observed throughout the proximal limb buds as well as the branchial 
arches (Coy and Borycki, 2010; Maeda et al., 2002; Waskiewicz et al., 2001).     
As stated earlier, the zebrafish have undergone an additional teleost specific genome 
duplication event resulting in duplicate copies of the meis genes (Amores et al., 1998).  Due 
to the evolutionary loss of coding exons, zebrafish have lost the second Meis gene (meis1.2) 
and only possesses the meis1.1, or meis1 gene as it is commonly referred (Irimia et al., 2011).  
The Meis1 gene is believed to play a major role in the patterning of hindbrain segmentation 
(Waskiewicz et al., 2001).  In zebrafish studies, mutating the meis1.1 gene so that its protein 
was non-functional was shown to result in disorganization in the compartmentalization of the 
hindbrain (Waskiewicz et al., 2001).  Such deformation is believed to be a direct result of 
Hox protein inhibition caused by insufficient meis1 cofactor functionality (Waskiewicz et al., 
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2001).  The Meis1 gene is also believed to help in the embryonic development of other 
regions of the central nervous system by directing the regulation of Sox3 and in the 
positioning of neurons in the dorsal horn of the developing spinal cord (Mojsin and 
Stevanovic, 2010; Rottkamp et al., 2008).   Aside from neuronal roles, Meis1 is involved in 
the construction and regulation of limb development (Mercader et al., 1999).  In chicken 
studies, the localization of Meis1 under the direction of retinoic acid to vertebrate limb 
proximal areas was found to play a role in cell and regional differentiation along the 
proximodistal axis of the limb (Mercader et al., 1999; Mercader et al., 2000; Mercader et al., 
2005).  The Meis1 gene has also been implicated in the proliferation, positioning, and 
maintenance of retinal progenitor cells throughout the period of retinal neurogenesis by 
influencing the expression of cell cycle control proteins (Bessa et al., 2008; French et al., 
2007; Heine et al., 2008).  Meis1 genes have been determined to play roles in the 
hematopoietic processes as Meis1 deficiencies result in blood vessel abnormalities, arterial 
deficiencies, and hemorrhaging (Azcoitia et al., 2005; Hisa et al., 2004).  Lastly, research has 
shown that the Meis1 gene helps direct the expression of Pax6, in turn helping drive 
pancreatic islet cell differentiation (Carbe et al., 2012; Zhang et al., 2006).  
The second of the Meis genes, Meis2, has been revealed to show expression in a wide 
variety of areas during embryonic development including the forebrain, midbrain, hindbrain, 
branchial arches, somites, mesoderm, limb buds, neural tube, spinal cord, and developing eye 
as well as the female genital tract (Cecconi et al., 1997; Coy and Borycki, 2010; Heine et al., 
2008; Mercader et al., 2005; Oulad-Abdelghani et al., 1997; Waskiewicz et al., 2001).  The 
teleost specific genome duplication event resulted in two separate Meis2 genes seen within 
the genome of zebrafish:  meis2a (meis2.2) and meis2b (meis2.1) (Biemar et al., 2001; 
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Waskiewicz et al., 2001; Zerucha and Prince, 2001).  In zebrafish, meis2b is seen expressed 
early throughout the embryo, but expression becomes more localized into distinct domains 
within the forebrain, midbrain, hindbrain, spinal cord, and retina as development continues 
(Biemar et al., 2001; Zerucha and Prince, 2001).  The expression of meis2a is similar to that 
for meis2b with expression seen in a few additional areas such as the limb buds and branchial 
arches (Coy and Borycki, 2010; Mercader et al., 1999; Mercader et al., 2000; Waskiewicz et 
al., 2001). 
Similar to the Meis1 gene, the Meis2 gene has been implicated in development of the 
eye through its interaction with Pax6 expression, and is believed to help with the 
proliferation of the undifferentiated cells found in the early retina (Heine et al., 2008; Zhang 
et al., 2002).  Research has also shown that the removal of microRNA miR-204 expression 
leads to a malformed eye displaying abnormal lens formation and an unusual dorsal-ventral 
patterning of the retina (Conte et al., 2010).  Meis2 is believed to serve as a target for proper 
miR-204 function which is elevated in situations where miR-204 is removed leading to the 
dysfunctional phenotype (Conte et al., 2010).  Further implicating the Meis2 gene with 
neuron development is the abundance of Meis2 expression seen in the lateral ganglionic 
eminence where it marks striatal progenitor neurons and subsets of amacrine cells for 
differentiation (Bumsted-O'Brien et al., 2007; Toresson et al., 1999).  Conversely, Meis2 
expression has been shown to be down regulated prior to actual retinal differentiation by 
sonic hedgehog signaling indicating that retinal differentiation may vary from region to 
region (Heine et al., 2009).  As with the Meis1 genes, the Meis2 genes serve as targets for 
retinoic acid, help to specify cellular differentiation in the limb, and construct the 
proximodistal axis of limbs (Mercader et al., 2005).  Successful limb development depends 
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on the restriction of Meis2 to proximal regions of the limb and such localization is enforced 
by orthologs of Drosophila dpp genes and Hoxd genes (Capdevila et al., 1999).  The Meis2 
proteins also play important roles in the pancreas but in a very different way than that seen 
by the Meis1 proteins (Liu et al., 2001).  Within the developing pancreas, the Meis2b 
cofactor forms a trimer complex with PDX1 and PBX1b which subsequently participates in 
the activation of the ELA1 enhancer in pancreatic acinar cells, in turn helping in the 
formation of the pancreas’s exocrine functions and eventual excretion of digestive enzymes 
(Liu et al., 2001).  Aside from these major roles, the Meis2 gene has been implicated with the 
development of the cardiac septum, somitic differentiation leading to subsequent 
segmentation, and the inhibition of myeloid differentiation (Cecconi et al., 1997; Crowley et 
al., 2010; Fujino et al., 2001).  Of special interest is the discovery that Meis2 cofactors were 
found to be expressed in the islands of Calleja within the striatum of primate brains 
(Takahashi et al., 2008).  The islands of Calleja are believed to aid in reward processing and 
the drug addiction pathways (Takahashi et al., 2008). 
The third member of the Meis gene family is Meis3, whose expression is first seen 
during the gastrula stage and has its most notable expression within the caudal hindbrain 
where it eventually fades out completely (Sagerstrom et al., 2001; Salzberg et al., 1999; 
Waskiewicz et al., 2001).  In time, during later steps of development including segmentation, 
Meis3 expression is seen in the somites, the budding pectoral fin, the neural tube, and cells 
immediately adjacent to embryonic pancreatic cells (diIorio et al., 2007; Sagerstrom et al., 
2001; Waskiewicz et al., 2001).  As is the case with the meis1.2 gene, it appears as if the 
second Meis3 gene (meis3.2) has been lost from the zebrafish genome since the teleost 
specific genome duplication event (Waskiewicz et al., 2001).     
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The Meis3 cofactors are extremely important in the formation of the posterior 
hindbrain (Choe et al., 2002; Salzberg et al., 1999).  Ectopic Meis3 expression in the anterior 
regions of embryos can lead to a loss of forebrain, midbrain, and eye structures and an 
increased expression of posterior neural markers in those same areas (Salzberg et al., 1999; 
Vlachakis et al., 2001).   Research has shown that such truncations and malformations are the 
result of the proteins Hoxb1b, Pbx4, and Meis3 forming a trimer complex (Vlachakis et al., 
2000; Vlachakis et al., 2001).  This trimer is found endogenously during development in the 
hindbrain to aid in specification and subsequent development, but can also influence the 
expression profiles and development in other anatomical areas (Vlachakis et al., 2001).  In 
Meis3 antisense morpholino oligonucleotides and other loss of function studies, anterior 
neural structures were expanded towards posterior regions and posterior neural tissues in the 
hindbrain were disturbed (Choe et al., 2002; Dibner et al., 2001).  Thus, it appears as if 
Meis3 is extremely important in hindbrain development as well as hindbrain differentiation.  
The Meis3 gene, like the other two previously described Meis genes play a role in pancreatic 
development and in the regulation of insulin production by controlling endoderm patterning 
and pancreas gene expression (diIorio et al., 2007).  The Meis3 gene has also been implicated 
in histone acetylation as well as helping in the organization of the neural plate (Choe et al., 
2009; Elkouby et al., 2010).  Although they have been found in zebrafish, the Meis4 genes 
have not been exclusively analyzed for expression or function since being identified 
previously (Waskiewicz et al., 2001). 
Thus, it is evident how extensive the Meis genes expression patterns are in embryos 
and how important those same genes are during the processes of embryonic development.  
Although much has been revealed concerning the Meis gene’s expression patterns and 
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developmental roles, little is known about Meis gene regulation.  In order to gain a better 
understanding of Meis gene regulation, putative cis-regulatory elements must first be 
identified (Fisher et al., 2006; Hughes et al., 2005).  Due to the selective evolutionary 
pressure and the subsequent sequence conservation that characterizes cis-regulatory 
elements, phylogenetic footprinting can be used to identify and locate HCNEs which have 
been shown to be candidates for cis-regulatory elements (Fisher et al., 2006; Hughes et al., 
2005; Kikuta et al., 2007a; Kikuta et al., 2007b; Woolfe et al., 2005).  The identification of 
HCNEs that potentially possess cis-regulatory function and direct the expression of the 
meis2a gene was done previously in the Zerucha lab (Wellington and Zerucha, unpublished).  
Making use of the fully published and publicly available human genome, approximately one 
million base pairs upstream and downstream of the human MEIS2 sequence was analyzed for 
any known Hox transcription factor binding sites.  After identifying the numerous binding 
sites, each one was analyzed via NCBI’s BLAST to see if the Hox binding sites and the local 
sequences surrounding the binding sites were conserved across human (Homo sapiens), 
mouse (Mus musculus), chicken (Gallus gallus), zebrafish (Danio rerio), and pufferfish 
(Takifugu rubripes).  Furthermore, multiple sequence alignments were executed to classify 
each HCNE and elucidate the levels of evolutionary conservation present between the 
orthologous elements.    
The phylogenetic footprinting and analysis of the human MEIS2 sequence resulted in 
the discovery of 4 HCNEs that have been named Meis2 downstream elements (m2de) 1-4 
(Wellington and Zerucha, unpublished).  The first HCNE, named m2de1, is found 220 Kb 
downstream of MEIS2 in humans, 220 Kb downstream of Meis2 in mice, 120 Kb 
downstream of Meis2 in chickens, and 40 Kb downstream of meis2a in zebrafish (Fig. 1).  
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The other three HCNEs that were discovered (m2de2, m2de3, and m2de4) were not found in 
zebrafish, but were found to be conserved downstream of Meis2 in humans, mice, and 
chickens indicating tetrapod lineage specificity (Fig. 1).  The second HCNE, named m2de2, 
is found 210 Kb downstream of MEIS2 in humans, 210 Kb downstream of Meis2 in mice, 
and 130 Kb downstream of Meis2 in chickens (Fig. 1).  The third HCNE, named m2de3, is 
found 250 Kb downstream of MEIS2 in humans, 260 Kb downstream of Meis2 in mice, and 
150 Kb downstream of Meis2 in chickens (Fig. 1).  The fourth HCNE, named m2de4, is 
found 440 Kb downstream of MEIS2 in humans, 415 Kb downstream of Meis2 in mice, and 
215 Kb downstream of Meis2 in chickens (Fig. 1).  Although four HCNEs were found, the 
research presented in this thesis concerns the m2de1 element only.   
For the m2de1 element, it was found that a 450 nucleotide region is conserved within 
which exists a 260 nucleotide region that is highly conserved having 68% sequence 
conservation between humans and zebrafish (Fig. 2).  It cannot be ruled out that there may be 
important regions that are less well conserved that extend beyond this as well (Fig. 2).  
Within the 260 nucleotide m2de1 element core, there are two conserved transcription factor 
binding sites for Hox proteins (ATTA / TAAT) (Popperl and Featherstone, 1992), a Pbx 
transcription factor binding site (ATCA / TGAT) (Chang et al., 1997; Fujino et al., 2001; 
Huang et al., 2005), and a conserved Meis transcription factor binding site (CTGTC / 
GACAG) (Chang et al., 1997; Fujino et al., 2001; Zhang et al., 2006) (Fig. 2).  Additionally, 
three potential Hox transcription factor binding sites (ATTA / TAAT) have been identified 
within adjacent regions as well (Fig. 2). 
 
24 
 
 
Fig. 1.  Schematic diagram of the relative positions of the m2de1 elements.  The relative 
positioning of the discovered m2de (1-4) elements in comparison to the Meis2 gene and to 
each other in the genomes of humans, mouse, chicken and zebrafish is revealed.  The 
diamonds shown above mark the positioning of the m2de (1-4) elements:  red represents the 
m2de1 element, green represents the m2de2 element, blue represents the m2de3 element, and 
orange represents the m2de4 element. 
Meis2a 
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Fig. 2.  Multiple sequence alignment for the m2de1 element.  The multiple sequence 
alignment was executed in an effort to elucidate areas of conservation within the m2de1 
element across chicken (Gallus Gallus; Gg), mouse (Mus musculus; Mm), human (Homo 
sapiens; Hs), and zebrafish (Danio rerio; Dr).  In all, 585 base pairs of sequence that may 
possess cis-regulatory function are shown aligned.  Areas highlighted in red are conserved 
across all vertebrates analyzed.  Areas highlighted in grey represent the 260 base pairs of 
sequence that show the highest amount of sequence conservation.  Arrows point to the 2 
nucleotides that form the boundaries for the 450 base pair sequence chosen to be used in the 
m2de1 vector construction.  The area highlighted in green is a potential Meis transcription 
factor binding site.  The area highlighted in yellow is a potential Pbx transcription factor 
 
26 
 
binding site.  The areas highlighted in light blue are potential Hox transcription factor 
binding sites.  The area highlighted in purple is another potential Hox transcription factor 
binding site that was mutated using PCR driven nucleotide mutagenesis.  Any binding sites 
that are not within the sequence indicated by the arrow boundaries have been purposely 
ignored as they were never included in the sequence chosen for vector construction. 
   
In order to test the functionality of the newly discovered m2de1 element, it must be 
coupled with a reporter gene and a minimal promoter, introduced into developing embryos, 
and analyzed for reporter gene expression ( Fisher et al., 2006; Kwan et al., 2007; Li et al., 
2010; Pauls et al., 2012; Zerucha et al., 2000).  The minimal promoter serves to drive 
reporter gene expression if the adjacent putative cis-regulatory element binds transcriptional 
proteins (Fisher et al., 2006; Li et al., 2010).  If the isolated m2de1 element is a functional 
cis-regulatory element, the spatiotemporal characteristics of reporter gene expression patterns 
should recapitulate the endogenous expression of any gene the HCNE serves to regulate 
(Fisher et al., 2006; Li et al., 2010; Parker et al., 2011).   
The organism Danio rerio, commonly known as the zebrafish, is a perfect model 
organism for transgenic studies (Udvadia and Linney, 2003).  The zebrafish is extremely 
fecund, laying numerous eggs in single fertilization events that are not only fertilized 
externally, but also develop externally as well (Grunwald and Eisen, 2002; Parichy et al., 
2009; Shin and Fishman, 2002).  Also, the embryos are transparent and develop rapidly 
making it easier to visualize internal development, microinject, and ultimately view the 
embryos for reporter gene expression through confocal microscopy (Udvadia and Linney, 
2003).  The gene Green Fluorescent Protein (GFP) is the reporter of choice when doing 
transgenic zebrafish studies due to its stability and ease of visualization within the relatively 
clear embryos (Amsterdam et al., 1995; Chalfie et al., 1994).           
 
27 
 
The purpose of this study was to examine the functionality of a putative regulatory 
element that we hypothesize potentially directs the expression of the Meis2 gene.  Here we 
propose that the previously discovered m2de1 element has putative cis-regulatory function, 
directing reporter gene expression in a manner consistent with meis2a expression in Danio 
rerio. 
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MATERIALS AND METHODS 
Zebrafish Husbandry 
 The zebrafish used for study were housed in a Marine Biotech Z-mod (Aquatic 
Habitats, Apopka, FL) closed system.  The system was maintained at a constant temperature 
of 27ºC and was programmed for a regimented 14 hour light, 10 hour dark cycle.  
Genetically controlled zebrafish strains AB, AB*, and TU (Zebrafish International Resource 
Center) as well as non-genetically controlled wild-type strains (Carolina Biological, 
Burlington, NC) were kept in the system.  The water quality of the system was checked on a 
daily basis to insure that the pH of the water was kept between 7.0 and 7.4 and that the 
conductivity stayed between 450 and 600 milliSiemens per meter (mS/m).  The adult 
zebrafish were housed in individual, 1 L aquaria housing a maximum of six fish per 
aquarium.  Attempts were made to keep the number of males and females in relatively equal 
ratios within the individual aquariums as well. 
To maintain each genetic line and in order to microinject our reporter constructs for 
screening, adult zebrafish first had to be bred to obtain embryos.  Fish of the same genetic 
line were placed into breeding chambers in a 1 L aquarium the day before crossing such that 
males were separated from females through the utilization of a specialized tank divider 
(Aquatic Habitats).  The tank divider served two purposes: to prevent earlier than desired 
breeding and to increase sexual aggressiveness.  The number of adult males and females used 
in each cross varied, but it was determined that two males and three females resulted in the 
most successful spawning.  The next morning, on the day microinjections were to be carried 
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out, the tank divider was pulled 30 minutes after the system lights had come on to wake the 
fish.  Once in physical proximity to each other, the females would release their eggs and the 
males would fertilize them externally.  Adults were generally allowed to breed for 30 
minutes in order to maximize the amount of embryos received.  This time constraint was 
especially important for obtaining embryos that needed to be within the 1-2 cell stages for 
successful microinjection.  Fertilized eggs fell through the porous bottom of the breeding 
chambers and were harvested using a fine mesh filter to catch the embryos while allowing 
the excess breeding chamber water to flow through.  The adult fish were placed into a 
separate 1L aquarium and put back into the system.  Embryos were then washed using 
Reverse Osmosis (RO) water from a squirt bottle and placed into a large glass dish where 
they were raised in 1X Danieau Buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 
mM Ca(NO3)2, 5 mM HEPES pH 7.6).  The embryos were placed in a VWR Mini Incubator 
set at 27ºC for 5 days with dead embryos and debris removed daily. 
 At 5 days post fertilization (dpf), the fry were placed into 1 L aquariums in the system 
that were approximately 40% full with 1x Danieau Buffer.  Also at this time, feeding with 
fine particulate dry food (ZM-50; Zeigler) began twice daily.  Daily, all dead fry, debris, and 
25% of the 1x Danieau Buffer was removed from the aquarium using a turkey baster and 
wide bore pipette.  Fresh 1x Danieau Buffer was then added to replenish dissolved oxygen 
levels, and to prevent a nitrogenous waste buildup.  Fry were kept in this manner until 20 dpf.    
 At 20 dpf, the majority of the 1x Danieau Buffer was removed from the 1L aquariums 
and a gentle drip of system water was introduced to the tank in order to acclimate the young 
fish to the system water.  At this point, feedings were reduced to once daily, but the size of 
the dry food was continually increased as development of the fry progressed (ZM-100, ZM-
 
30 
 
200, ZM-300, ZM-400; Zeigler).  Once the young zebrafish had begun readily eating the 
ZM-200 dry food, they were allowed to begin consuming 2 day old live brine shrimp (INVE 
Aquaculture, Salt Lake City, UT).  As the fry continued to grow, they were separated into 
multiple 1L aquariums such that each individual aquarium had a maximum of 6 zebrafish as 
noted previously.  This was done simply to prevent overpopulation and promote further, 
optimal development.  The zebrafish reached adulthood and sexual maturity around 3 to 4 
months post fertilization.  Adults were fed Zeigler Adult Zebrafish Complete Diet (Zeigler) 
once daily while also receiving daily feedings of 2 day old live brine shrimp.  
 Zebrafish and Mouse HCNE Isolation from Genomic DNA 
The identified m2de1 element found in zebrafish was isolated from the total genomic 
DNA through Polymerase Chain Reaction (PCR) amplification.  First, total genomic DNA 
had to be isolated from a zebrafish of the AB* strain.  The selected zebrafish was euthanized 
using a Tricaine solution (300 ng/L).  The fish was then cut up into small pieces using a razor 
blade and the procedure for “Mammalian Tissue and Mouse/Rat Tail Lysate Protocol” found 
within the Invitrogen PureLink Genomic DNA Mini Kit (Invitrogen) was followed.  25 mg 
fish tissue placed in a 1.5 ml microcentrifuge tube with 180 µl PureLink Genomic Digestion 
Buffer and 20 µl Proteinase K; tube was placed on a heating block set at 55ºC overnight; 
lysate was centrifuged for 3 minutes at room temperature and transferred to a new 1.5 ml 
microcentrifuge tube; 20 µl RNase A added to lysate and vortexed; incubated at room 
temperature for 2 minutes; 200 µl PureLink Genomic Lysis/Binding Buffer added and 
vortexed; 200 µl 95% ethanol added and vortexed; lysate added to the PureLink Spin 
Column placed in a Collection Tube and centrifuged at 10000 x g for 1 minute; the 
Collection Tube containing the elution was discarded and a new Collection Tube was placed 
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under the spin column; 500 µl Wash Buffer 1 added to the Spin Column and centrifuged at 
10000 x g for 1 minute; the Collection Tube containing the elution was discarded and a new 
Collection Tube was placed under the spin column; 500 µl Wash Buffer 2 added to the Spin 
Column and centrifuged at 10000 x g for 3 minutes;  the Collection Tube containing the 
elution was discarded and a new 1.5 ml microcentrifuge tube was placed under the spin 
column; 100 µl RO water was added to the Spin Column and incubated at room temperature 
for 1 minute; Spin Column centrifuged at 10000 x g for 1 minute; another 100 µl RO water 
was added to the Spin Column and then centrifuged at 10000 x g for 90 seconds; genomic 
DNA was quantified by spectrophotometry and stored at -20ºC.  Genomic DNA 
concentration was quantified by NanoDrop® ND-1000 spectrophotometry.   
The zebrafish m2de1 element was then isolated from the total genomic DNA by PCR.  
The two primers, Dr-m2de1-3 and Dr-m2de1-5b (Table 1), used for the PCR protocol were 
designed bearing in mind the sequence and species that the HCNE was being isolated from in 
order to insure that correct and efficient amplification occurred.  
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Table 1.  The nomenclature used to identify the various primers as well as the exact 
sequences of the primers used. 
 
Primer Name Primer Sequence 
Dr-m2de1-5b 
Dr-m2de1-3 
M13 Forward 
M13 Reverse 
5’-attB2-TOPO primer 
 
3’-attB1-TOPO primer 
 
Sense: 5’-Gateway Seq 
Antisense: 3’-Gateway Seq 
TATACCATGGAGGTCGGGTTTAAAGGA 
GCTCATTATAAGGCCGTGCATG 
GTAAAACGACGGCCAG 
CAGGAAACAGCTATGAC 
GGGGACCACTTTGTACAAGAAAGCTGGGT/GAGCTCGG
ATCCACTAGTAAC 
 
GGGGACAAGTTTGTACAAAAAAGCAGGCT/TCACTATA
GGGCGAATTGGG 
 
GCAATCCTGCAGTGCTGAAA 
GGACTTCCTACGTCACTGGA 
 
 The PCR protocol from the Invitrogen TOPO TA Cloning Procedure was used as a 
guideline when performing the HCNE isolation.  The zebrafish HCNE sequence specific 
primers listed above (Dr-m2de1-3 and Dr-m2de1-5b) were used in conjunction with 
Phusion® High-Fidelity DNA Polymerase (NEB M0530L, Ipswich, MA) and the general 
reaction mixture associated with Phusion® based amplification [1.0 µl zebrafish genomic 
DNA (20.4 ng/µl), 1.0 µl 3’ Dr-m2de1-3 primer (50 pmol/µl), 1.0 µl 5’ Dr-m2de1-5b primer 
(50pmol/µl), 5.0 µl Phusion® 5X HF Buffer, 0.5 µl dNTPs (10 mM), 15.5 µl RO water, and 
1.0 µl Phusion® High-Fidelity DNA Polymerase (NEB M0530L)].  The PCR mixture was 
then placed into a GeneAmp® PCR System 9700 (Applied Bioscience) set at parameters 
designated for optimal amplification according to the selected primers and HCNE length [one 
initial DNA melt at 95ºC for 30 minutes, 35 cycles (each cycle consisting of a 30 second melt 
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at 95ºC, a 30 second annealing at 61ºC, and a 30 second extension at 72ºC), 10 minutes at 
72ºC post-cycle completion, and 4ºC for an indefinite amount of time]. 
 Once the PCR reaction was complete, 10 µl of the zebrafish m2de1 product was run 
on a 1% agarose TBE gel containing ethidium bromide (0.3 µg/ml) set at 115 Volts for 40 
minutes.  This was done to insure that correct and sufficient amplification had actually 
occurred.  The zebrafish m2de1 PCR product concentration was quantified by NanoDrop® 
ND-1000 spectrophotometry.  The zebrafish m2de1 element was also sent off for Sanger 
DNA sequencing [performed by Cornell University’s Life Sciences Core Laboratories using 
the Dr-m2de1-3 and Dr-m2de1-5b primers (Table 1)].  HCNEs found in the mouse genome 
were previously isolated and amplified using a similar protocol as detailed above involving 
PCR (Nelson, 2011).         
HCNE TOPO® TA Cloning® 
 The isolated m2de1 elements from zebrafish and mouse were then cloned into the 
pCR®2.1-TOPO® cloning vector.  This particular process was carried out for both the 
zebrafish and mouse HCNEs following standard Invitrogen TOPO TA Cloning® protocol 
(Invitrogen 45-0641).  The addition of 3’ A’s, the ligation of each HCNE PCR product into 
the pCR®2.1-TOPO® cloning vector, the heat shock transformation of the vector into One 
Shot® TOP10 Chemically Competent E. coli cells, the subsequent plasmid isolation through 
miniprep procedure, and eventual analysis of the resulting plasmid through restriction 
digestion and gel electrophoresis testing was all carried out by a previous member of the 
Zerucha lab (Nelson, 2011).  The pCR®2.1-TOPO® cloning vector containing the zebrafish 
m2de1 element was also sent off for Sanger DNA sequencing [performed by Cornell 
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University’s Life Sciences Core Laboratories using universal M13 Forward and M13 
Reverse primers (Table 1)].  
Isolating HCNEs from pCR®2.1-TOPO® 
 The development of the reporter constructs containing the transgenic expression 
cassettes was done using Gateway® Technology’s Cloning System.  Vector construction was 
the result of a two-part subcloning process where the HCNEs were subcloned into the 
pDONR221 vector and then the pGW_cfosEGFP vector.  Four sets of reporter constructs 
were created:  construct with the zebrafish m2de1 element in forward orientation (pDr-
m2de1F-cfos-EGFP), construct with the zebrafish m2de1 element in reverse orientation 
(pDr-m2de1R-cfos-EGFP), construct with mouse m2de1 element in forward orientation 
(pMm-m2de1F-cfos-EGFP), and construct with mouse m2de1 element in reverse orientation 
(pMm-m2de1R-cfos-EGFP).  In order to produce the transgenic reporter construct containing 
the zebrafish element in its reverse orientation, the zebrafish HCNE had to first be isolated 
out of the pCR®2.1-TOPO® plasmid and prepared for reverse orientation insertion by PCR.  
The zebrafish m2de1 element was previously prepared for forward orientation insertion 
(Nelson, 2011).  The isolation and amplification of the HCNE was executed using pCR®2.1-
TOPO® plasmid sequence specific primers, 5’-attB2-TOPO and 3’-attB1-TOPO (Table 1), 
and Phusion® DNA polymerase [1.0 µl zebrafish plasmid DNA, 1.0 µl 3’-attB1-TOPO 
primer (50pmol/µl), 1.0 µl 5’-attB2-TOPO primer (50pmol/µl), 5.0 µl Phusion® 5X HF 
Buffer, 0.5 µl dNTPs (10 mM), 16.3 µl RO water, and 0.2 µl Phusion® High-Fidelity DNA 
Polymerase (NEB M0530L)].   The PCR mixture was then placed into a GeneAmp® PCR 
System 9700 (Applied Bioscience) set at parameters designated for optimal amplification 
according to the selected primers and HCNE length [one initial DNA melt at 98ºC for 90 
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seconds, 35 cycles (each cycle consisting of a 30 second melt at 98ºC, a 30 second annealing 
at 62.9ºC, and a 30 second extension at 72ºC), 7 minutes at 72ºC post-cycle completion, and 
4ºC for an indefinite amount of time].  The primers used in the PCR reaction were developed 
such that the 3’-attB1-TOPO primer had an adjacent attB1 site and the 5’-attB2-TOPO 
primer had an adjacent attB2 site.  Both attB1 and attB2 sequences were sequence extensions 
added onto the primers and subsequently, the exponentially produced HCNE sequences via 
the PCR mechanism.  The attB1 and attB2 sequences were not necessary for actual primer 
binding.  Furthermore, the 5’primer bound to the pCR®2.1-TOPO® plasmid 5’ polyclonal 
sequence and the 3’ primer bound to the pCR®2.1-TOPO® plasmid 3’ polyclonal sequence.  
The resulting PCR product contained the zebrafish m2de1 element flanked by attB1 and 
attB2 sites (Fig. 3).  Once the PCR reaction was complete, 5 µl of the zebrafish m2de1 
product was run on a 1% agarose TBE gel containing ethidium bromide (0.3 µg/ml) set at 
115 Volts for 45 minutes.  This was done to insure that correct and sufficient amplification 
had actually occurred. 
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Zebrafish m2de1 Element Ready for Forward Orientation Insertion into the Donor Vector  
 
  
 
Zebrafish m2de1 Element Ready for Reverse Orientation Insertion into the Donor Vector  
 
 
 
 
Mouse m2de1 Element Ready for Forward Orientation Insertion into the Donor Vector 
 
 
 
 
Mouse m2de1 Element Ready for Reverse Orientation Insertion into the Donor Vector 
 
 
 
Fig. 3.  Zebrafish and mouse m2de1 PCR products post pCR®2.1-TOPO® isolation.  
Representations of the spatial orientations of the zebrafish HCNEs and their respective attB1 
and attB2 sites prior to cloning into the donor vector. One of the primers used in the PCR 
reaction for preparing the HCNE in its forward orientation had an attB2 sequence adjacent to 
its 3’ primer (3’-attB2-TOPO) and the other had an attB1 sequence adjacent to its 5’ primer 
(5’-attB1-TOPO).  One of the primers used in the PCR reaction for preparing the HCNE in 
its reverse orientation had an attB1 sequence adjacent to its 3’ primer (3’-attB1-TOPO) and 
the other had an attB2 sequence adjacent to its 5’ primer (5’-attB2-TOPO).  Representations 
of the spatial orientations of the mouse HCNEs and their respective attB1 and attB2 sites 
prior to cloning into the donor vector are shown as well.  In all the sequences above, the 
m2de1 element is in its forward orientation (5’ to 3’).  For the elements primed for reverse 
orientation insertion, not until donor vector recombination via the BP reaction will the HCNE 
be adapted to its reverse orientation.     
 
The zebrafish m2de1 PCR product was then cleaned up using the Wizard® SV Gel 
and PCR Clean-Up System (Promega TB308) using provided instructions involving 
purification by centrifugation.  1 volume of Membrane Binding Solution was added to an 
equal volume of PCR reaction solution; the PCR mixture was put in an SV Minicolumn that 
was placed in a provided Collection Tube and allowed to incubate at room temperature for 1 
minute; the SV Minicolumn was centrifuged at maximum speed for 1 minute; the liquid in 
attB2 attB1 
attB2 attB1 
m2de1 
m2de1 
attB1 attB2 m2de1 
attB2 attB1 m2de1 
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the Collection Tube was discarded and the Collection Tube was placed back under the SV 
Minicolumn; 700 µl of Membrane Wash Solution was added to the SV Minicolumn and 
centrifuged at maximum speed for 1 minute;  the liquid in the Collection Tube was discarded 
and the Collection Tube was placed back under the SV Minicolumn; 500 µl of Membrane 
Wash Solution was added to the SV Minicolumn and centrifuged at maximum speed for 5 
minutes; the Collection Tube was emptied and placed back under the SV Minicolumn; 
centrifuged at maximum speed for 1 minute; the SV Minicolumn was placed over a 1.5 ml 
microcentrifuge tube and 50 µl of Nuclease-Free Water was added; SV column was 
incubated with the water for 1 minute and centrifuged at maximum speed for 1 minute; 
eluted DNA was stored at -20ºC.  The zebrafish m2de1 PCR product concentration was 
quantified by NanoDrop® ND-1000 spectrophotometry.  The mouse m2de1 PCR product 
was isolated out of the pCR®2.1-TOPO® plasmid and prepared for both forward and reverse 
orientation insertion via PCR previously (Nelson, 2011).  The final mouse m2de1 PCR 
products possessed the same attB site spatial orientations as the final zebrafish m2de1 PCR 
products. 
Construction of Middle Entry Vectors  
 Next, the zebrafish m2de1 element was inserted in its reverse orientation into the 
previously mentioned donor plasmid, pDONR221 in a process known as the BP reaction 
(Fig. 4).  The BP reaction utilizes Gateway® BP ClonaseTM II Enzyme Mix (Invitrogen 
865071, Grand Island, NY) and enzyme assisted recombination to construct middle entry 
vectors.  The resulting middle entry vector containing the zebrafish HCNE in its reverse 
orientation was named pME-Dr-m2de1R.   
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Fig. 4.  Schematic diagram of the Gateway® BP reaction.  In this reaction, the zebrafish 
m2de1 element flanked by aatB2 and attB1 cloning sites recombined with the donor vector 
(pDONR221).  With the guidance of the BP ClonaseTM II, compatible sequences between 
attB1-attP1 and attB2-attP2 are recognized, and the HCNE sequence between the attB2 and 
attB1 sites is translocated into the pDONR221 vector creating the middle entry vector, pME-
Dr-m2de1R.  The orientation of the attB1-attP1 and attB2-attP2 sites upon recombination 
results in the reverse insertion of the HCNE into the pDONR221 vector. 
 
The pDONR221 donor plasmid was transformed into One Shot® ccdB SurvivalTM 2 
T1R Competent Cells (Invitrogen A10460) by heat shock, subsequently grown on LB-
Chloramphenicol (30 mg/µl) + Kanamycin (50 mg/µl) plates, and prepared for use.  Half 
reaction amounts were utilized for the BP reaction for a total reaction mixture of 5.0 µl [0.33 
µl pDONR221 (25 fmol), 0.92 µl zebrafish HCNE PCR product (25 fmol), 1.0 µl BP 
ClonaseTMII, 2.75 µl TE (10 mM Tris-Cl, 1 mM EDTA pH 7.4)].  The Gateway® 
Technology Cloning Manual provided a formula to determine the amount of zebrafish m2de1 
element prepared for reverse insertion was needed for BP reaction success.  Once the amount 
of BP product in nanograms (ng) needed for the reaction was determined, the volume 
necessary was calculated using the known concentration of the BP reaction product 
determined via the spectrophotometry procedure.  The formula and numbers used for 
calculation are shown below: 
ng = (x fmoles) • (HCNE size in base pairs) • (660 fg/fmoles) • (1 ng/106 fg) 
ng = (25 fmoles) • (645 bp) • (660 fg/fmoles) • (1 ng/106 fg) 
attB2 attB1 m2de1 
Zebrafish m2de1 element Prepared for Reverse Insertion 
pDONR221 
attP1 attP2 ccdB+Chloramphenicol 
Byproduct 
pME-Dr-m2de1R 
attB1 attB2 ccdB+Chloramphenicol 
attL1 attL2 1ed2m 
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 The BP reaction was performed as indicated by the Gateway® manufacturer 
instructions.  The mixture was vortexed briefly; 1.0 µl BP ClonaseTM II Enzyme Mix was 
added to the reaction mixture; reaction was again vortexed briefly and then centrifuged 
quickly at low speed to pellet the reaction; and the reaction was run at room temperature 
overnight.  The reaction mixture was then transformed via heat-shock transformation into 
chemically competent DH5α E. coli.  2.5 µl of BP reaction mixture was incubated on ice 
with 50 µl of chemically competent DH5α E. coli cells for 15 minutes; the mixture was then 
incubated in a 42ºC water bath for 45 seconds; the mixture was incubated on ice for 2 
minutes; the cells were transferred to 1 ml room temperature SOC (0.5 g/L NaCl, 20 mM 
glucose, 20 g/L bacto-tryptone (BD 211705), 5 g/L bacto-yeast extract (BD 212750)); 
mixture was placed in a shaking incubator at 200 RPM and 37ºC for 90 minutes; the 
transformed cells were placed on an LB + Kanamycin (50 mg/µl) plate and incubated at 37ºC 
overnight.   
 After the transformation protocol, three colonies were chosen from the plate and used 
to inoculate cultures containing 3 ml LB + Kanamycin (50 mg/µl) and were grown overnight 
with shaking at 200RPM at 37ºC.  After the cultures had been given time to reach maximum 
growth, the plasmid DNA was isolated from the DH5α E. coli using the Promega Wizard 
Plus SV Miniprep DNA Purification System (Promega N2511).  3.0 ml of each culture was 
pelleted in a microcentrifuge for 5 minutes at 10000 x g; the cells were resuspended with 250 
µl of Cell Resuspension Solution; 250 µl of Cell Lysis Solution was added and inverted to 
mix; 10 µl Alkaline Protease Solution was added and inverted to mix; mixture was incubated 
at room temperature for 5 minutes; 350 µl Neutralization Solution was added and inverted to 
mix; mixture was centrifuged at 10000 x g for 10 minutes; the resulting cleared lysate was 
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put into the kit provided Spin Column that was placed into the provided Collection Tube; 
lysate was centrifuged at 10000 x g for 1 minute and the flowthrough was discarded; the Spin 
Column was placed back in the Collection Tube; 750 µl of Wash Solution was added to the 
Spin Column and then centrifuged at 10000 x g for 1 minute with the flowthrough being 
discarded; the Spin Column was placed back in the Collection Tube; 250 µl of Wash 
Solution was again added to the Spin Column and then centrifuged at 10000 x g for 1 minute 
with the flowthrough being discarded; the Spin Column was placed back in the Collection 
Tube; the column was centrifuged at 10000 x g for 2 minutes to remove any residual ethanol 
and the Collection Tube containing the flowthrough was discarded; the Spin Column was 
placed in a 1.5 ml microcentrifuge tube and 100 µl of Nuclease-Free Water was added to the 
Spin Colum; Spin Column was centrifuged at 10000 x g for 1 minute; DNA was stored at -20 
ºC.  The concentration of the prepared middle entry plasmid was quantified by NanoDrop® 
ND-1000 spectrophotometry.  The plasmid was also subjected to restriction digest testing for 
1 hour in a 37ºC water bath using the Restriction Enzymes BglII and EcoRI [6.0 µl middle 
entry plasmid DNA, 2.0 µl 10X EcoRI Buffer (NEB), 0.5 µl BglII (NEB R0144S), 0.5 µl 
EcoRI (NEB R0101S), and 11.0 µl RO water].  The digested plasmid was run on a 1% 
agarose TBE gel containing ethidium bromide (0.3 µg/ml) set at 130 Volts for 1 hour.  This 
was done to insure that the BP reaction had worked successfully and that insertion of the 
zebrafish HCNE in its reverse orientation had occurred.  The middle entry vector containing 
the zebrafish m2de1 element in its forward orientation (pME-Dr-m2de1F), the middle entry 
vector containing the mouse m2de1 element in its forward orientation (pME-Mm-m2de1F), 
and the middle entry vector containing the mouse m2de1 element in its reverse orientation 
(pME-Mm-m2de1R) were previously constructed (Nelson, 2011). 
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Construction of Transgenic Reporter Constructs 
 Next, the middle entry plasmid was used to relocate the reverse oriented zebrafish 
m2de1 element into the previously mentioned destination vector, pGW_cfosEGFP, in a 
process known as the LR reaction (Fig. 5).  The LR reaction utilizes Gateway® LR 
ClonaseTM II Plus Enzyme Mix (Invitrogen 12538120, Grand Island, NY) and enzyme 
assisted recombination to construct transgenic reporter constructs.  The resulting reporter 
construct containing the zebrafish HCNE in its reverse orientation was named pDr-m2de1R-
cfos-EGFP.   
 
 
 
 
 
 
 
 
 
Fig. 5.  Schematic diagram of the Gateway® LR reaction.  In this reaction, the middle entry 
vector (pME-Dr-m2de1R) flanked by aatL1 and attL2 cloning sites recombined with the 
destination vector pGW_cfosEGFP).  With the guidance of the LR ClonaseTM II Plus, 
compatible sequences between attL1-attR1 and attL2-attR2 are recognized, and the m2de1 
sequence between the attL1 and attL2 sites is translocated in its reverse orientation into the 
pGW_cfosEGFP vector creating the final construct, pDr-m2de1R-cfos-EGFP. 
 
 
The pGW_cfosEGFP destination vector was transformed into One Shot® ccdB 
SurvivalTM 2 T1R Competent Cells (Invitrogen A10460) by heat shock, subsequently grown 
pME-Dr-m2de1R 
attL1 attL2 1ed2m 
ccdB+Chloramphenicol 
pGW_cfosEGFP 
attR1
 
attR2 Tol2 Tol2 cfos-EGFP 
pDr-m2de1R-cfos-EGFP 
Tol2 1ed2m cfos-EGFP Tol2 
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on LB-Chloramphenicol (30 mg/µl) + Ampicillin (100 mg/µl) plates, and prepared for use.  
Half reaction amounts were utilized for the LR reaction for a total reaction mixture of 5.0 µl 
[0.64 µl pGW_cfosEGFP (10 fmol), 0.35 µl BP reaction product (10 fmol), 1.0 µl LR 
ClonaseTMII Plus Enzyme Mix, 3.01 µl TE (10 mM Tris-Cl, 1 mM EDTA pH 7.4)].  The 
Gateway® Technology Cloning Manual provided a formula to determine the amount of BP 
reaction product needed for LR reaction success.  Once the amount of BP product in 
nanograms (ng) needed for the reaction was determined, the volume necessary was 
calculated using the known concentration of the BP reaction product determined via the 
spectrophotometry procedure.  The formula and numbers used for calculation are shown 
below: 
ng = (x fmoles) • (HCNE size in base pairs) • (660 fg/fmoles) • (1 ng/106 fg) 
ng = (10 fmoles) • (645 bp) • (660 fg/fmoles) • (1 ng/106 fg) 
 The LR reaction was performed as indicated by the Gateway® manufacturer 
instructions [The mixture was vortexed briefly; 1.0 µl LR ClonaseTM II Plus Enzyme Mix 
was added to the reaction mixture; the reaction was again vortexed briefly and then 
centrifuged quickly at low speed to pellet the reaction; and the reaction was run at room 
temperature overnight].  The reaction mixture was then transformed via heat-shock 
transformation into One Shot® TOP10 Chemically Competent E. coli (Invitrogen C4040-
10).  2.5 µl of LR reaction mixture was incubated on ice with 50 µl of One Shot® TOP10 
Chemically Competent E. coli cells for 15 minutes; the mixture was then incubated in a 42ºC 
water bath for 45 seconds; the mixture was incubated on ice for 2 minutes; the cells were 
transferred to 1 ml room temperature SOC (0.5 g/L NaCl, 20 mM glucose, 20 g/L bacto-
tryptone (BD 211705), 5 g/L bacto-yeast extract (BD 212750)); mixture was placed in a 
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shaking incubator at 200 RPM and 37ºC for 90 minutes; and the transformed cells were 
placed on an LB + Ampicillin (100 mg/µl) plate and incubated at 37ºC overnight. 
 After the transformation protocol, three colonies were chosen from the plate and used 
to inoculate cultures containing 3 ml LB + Ampicillin (100 mg/µl) and were grown overnight 
with shaking at 200 RPM at 37ºC.  After the cultures had been given time to reach maximum 
growth, the plasmid DNA was isolated from the One Shot® TOP10 Chemically Competent 
E. coli using the Promega Wizard Plus SV Miniprep DNA Purification System (Promega 
N2511) as previously described.  The concentration of the prepared transgenic reporter 
construct was quantified by NanoDrop® ND-1000 spectrophotometry.  The plasmid was also 
subjected to restriction digest testing for 1 hour in a 37ºC water bath using the Restriction 
Enzyme EcoRI [6.0 µl transgenic reporter DNA, 2.0 µl 10X EcoRI Buffer (NEB), 1.0 µl 
EcoRI (NEB R0101S), and 11.0 µl RO water].  The digested plasmid was run on a 1% 
agarose TBE gel containing ethidium bromide (0.3 µg/ml) set at 130 Volts for 1 hour and 15 
minutes.  This was done to insure that the LR reaction had worked successfully and that 
insertion of the zebrafish m2de1 element had occurred.  For storage and future utilization, 
glycerol stocks were made for the transgenic reporter construct containing the zebrafish 
m2de1 in its reverse orientation.  750 ml culture and 750 ml LB + 30% Glycerol added to 
Nalgene Cryogenic Vials (Nalgene 5000-0020); mixture was vortexed to mix; the vials were 
placed in the -80ºC freezer.  The reporter construct containing the zebrafish m2de1 element 
in its forward orientation (pDr-m2de1F-cfos-EGFP), the reporter construct containing the 
mouse m2de1 element in its forward orientation (pMm-m2de1F-cfos-EGFP), and the reporter 
construct containing the mouse m2de1 element in its reverse orientation (pMm-m2de1R-
cfos-EGFP) were previously constructed (Nelson, 2011).   The pDr-m2de1F-cfos-EGFP 
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construct was also sent off for Sanger DNA sequencing [performed by Cornell University’s 
Life Sciences Core Laboratories using the Dr-m2de1-3 and Dr-m2de1-5b primers (Table 1)].   
Mutation of a Potential Hox Binding Site 
In order to analyze the impacts of a mutated potential transcription factor binding site 
within the zebrafish m2de1 element, PCR mutagenesis was performed using the 
QuikChange® II XL Site-Directed Mutagenesis Kit (Stratagene #200521).  Furthermore, 
previous research revealed that a sequence comparable to m2de1 drives Meis2 expression as 
well (Parker et al., 2011).  Sequence comparison between the zebrafish m2de1 element and 
the cis-regulatory element utilized by Parker et al. showed that the m2de1 element contained 
an additional Hox binding site, the previously stated TAAT sequence.  By eradicating this 
Hox binding site, it would then be possible to compare expression profiles driven by the two 
different elements.  The binding site mutated was a known Hox binding site bearing the 
sequence TAAT.   
First, primers were designed according to the primer design guidelines included in the 
QuikChange® II XL Site-Directed Mutagenesis Kit.  Both primers (Table 2) were 
constructed so that they contained the desired mutation (TAAT to TCGA), they annealed to 
the same sequence on opposite strands of the pDr-m2de1F-cfos-EGFP plasmid, and they had 
a melting temperature higher than 75ºC.  Furthermore, an additional guanine located directly 
adjacent to the Hox binding site was mutated as well (TAATG to TCGAT) via the primers.  
This TCGAT mutation sequence was chosen because it not only eradicates any Hox binding 
affinity the TAAT sequence may have had, but it also possesses a ClaI restriction site (5’ 
AT▼CGAT 3’) not seen in the original TAAT sequence as an adenine is located adjacent to 
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the 5’ end of the Hox binding site.  The additional ClaI site makes it relatively easy to 
determine if in fact the PCR mutagenesis was successful.   
Table 2.  The nomenclature used to identify each primer implemented in the mutation of the 
pDr-m2de1F-cfos-EGFP plasmid as well as the exact sequences of the primers.  The 
nucleotides in bold and underlined are those possessing the implemented mutations.  The 
black triangles indicate the recognition and cut site for the ClaI restriction enzyme. 
 
Primer Name Primer Sequence 
Dr-m2de1-
mut-R 
Dr-m2de1-
mut-F 
GAGTTGTACGTGCCGGAATAGC▼TATCGTTCCCGCTTAAGGTCG 
 
CTCAACATGCACGGCCTTAT▼CGATAGCAAGGGCGAATTCCAGG 
 
 The pDr-m2de1F-cfos-EGFP plasmid was then retrieved from the glycerol stock.  
Cells from glycerol stocks for the pDr-m2de1F-cfos-EGFP plasmid were streaked onto LB + 
Ampicillin (100 mg/µl) plates and incubated at 37ºC overnight; two colonies were chosen 
from each plate and used to inoculate cultures containing 3 ml LB + Ampicillin (100 mg/µl) 
and were grown overnight with shaking at 200 RPM at 37ºC.  The plasmid DNA was isolated 
from the One Shot® TOP10 Chemically Competent E. coli using the Promega Wizard Plus 
SV Miniprep DNA Purification System (Promega N2511) as previously described.  The 
concentration of the prepared plasmid was quantified by NanoDrop® ND-1000 
spectrophotometry.   
 The PCR mutagenesis was then executed following the protocol included with the 
QuikChange® II XL Site-Directed Mutagenesis Kit utilizing the primers listed in Table 2 
(Dr-m2de1-mut-R and Dr-m2de1-mut-F), PfuUltra HF DNA Polymerase (Stratagene) and 
the general reaction mixture associated with PfuUltra based amplification [0.15 µl pDr-
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m2de1F-cfos-EGFP plasmid DNA (10 ng), 0.125 µl Dr-m2de1-mut-R primer (125 ng), 0.125 
µl Dr-m2de1-mut-F primer (125 ng), 5.0 µl 10X reaction buffer, 1.0 µl dNTP mix, 3.0 µl of 
QuikSolution, 40.6 µl RO water, and 1.0 µl PfuUltra HF DNA Polymerase (Stratagene)].  
The PCR mixture was then placed into a GeneAmp® PCR System 9700 (Applied 
Bioscience) set at parameters designated for optimal amplification according to the 
QuikChange® II XL Site-Directed Mutagenesis Kit [1 initial DNA melt at 95ºC for 1 minute, 
18 cycles (each cycle consisting of a 50 second melt at 95ºC, a 50 second annealing at 60ºC, 
and a 8 minute extension at 68ºC), 7 minutes at 68ºC post-cycle completion, and 4ºC for an 
indefinite amount of time]. 
 After the PCR steps, the QuikChange® II XL Site-Directed Mutagenesis Kit protocol 
was utilized to retrieve the actual mutated m2de1 element.  The PCR reaction tube was 
incubated on ice for 2 minutes; 1.0 µl of the DpnI restriction enzyme was added directly to 
the PCR tube, and the solution was mixed by pipetting up and down several times; the PCR 
tube was spun down in a microcentrifuge at 10000x g for 1 minute; the PCR tube was 
incubated in a 37ºC water bath for 1 minute; during the incubation, the XL10-Gold 
ultracompetent (Stratagene) cells were thawed on ice; 45.0 µl of the XL10-Gold 
ultracompetent cells were put into a prechilled 14 ml Falcon® polypropylene tube (Falcon® 
2059); 2.0 µl of the β-Mercaptoethanol mix was added to the XL10-Gold ultracompetent 
cells and the contents were swirled gently;  the XL10-Gold ultracompetent cells were then 
incubated on ice for 10 minutes, while gently swirling them every 2 minutes; 2.0 µl of the 
DpnI digested DNA was added to the cells and the reaction was swirled gently and incubated 
on ice for 30 minutes; during the incubation, NZY+ broth (10.0 g NZ amine, 5.0 g yeast 
extract, 5.0 g NaCl, 12.5 ml of 1 M MgCl2, 12.5 ml of 1 M MgSO4, 20 ml of 20% glucose, 
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pH adjusted to 7.5 with NaOH, and adjusted to 1.0 L with RO water) was preheated in a 42ºC 
water bath; after the incubation, the reaction tube was placed in a 42ºC water bath for 30 
seconds; the reaction tube was then placed on ice for 2 minutes; 0.5 ml of the preheated 
NZY+ broth was added to the reaction tube and the mixture was incubated at 37ºC for 1 hour 
with shaking at 245 RPM; and after the incubation, 500 µl of the reaction mixture was spread 
evenly onto two LB + Ampicillin (100 mg/µl) plates and incubated overnight at 37ºC.  
After the overnight incubation, two colonies were chosen from the plates and used to 
inoculate cultures containing 3 ml LB + Ampicillin (100 mg/µl) and were grown overnight 
with shaking at 200 RPM at 37ºC.  Plasmid DNA was isolated from the XL10-Gold 
ultracompetent cells using the Promega Wizard Plus SV Miniprep DNA Purification System 
(Promega N2511) as previously described.  The concentration of the prepared mutant 
transgenic reporter construct (pDr-m2de1F-mut-cfos-EGFP) was quantified by NanoDrop® 
ND-1000 spectrophotometry.  The pDr-m2de1F-mut-cfos-EGFP plasmid and the unmutated 
pDr-m2de1F-cfos-EGFP plasmid were subjected to restriction digest testing overnight in a 
37ºC water bath using the Restriction Enzyme ClaI [10.0 µl transgenic reporter construct 
DNA, 2.0 µl 10X Buffer 4 (NEB), 0.2 µl 100X BSA (NEB),1.0 µl ClaI (NEB R0197S), and 
6.8 µl RO water].  The digested plasmids were run on a 1% agarose TBE gel containing 
ethidium bromide (0.3 µg/ml) set at 115 Volts for 1 hour and 10 minutes.  This was done to 
make sure that actual mutation of the TAAT site and introduction of a new ClaI restriction 
site had occurred.  The pDr-m2de1F-mut-cfos-EGFP construct was also sent off for Sanger 
DNA sequencing [performed by Cornell University’s Life Sciences Core Laboratories using 
the Sense: 5’-Gateway Seq and Antisense: 3’-Gateway Seq primers (Table 1)].  
Preparing the Constructs for Transgenic Analysis 
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 In order to retrieve sufficient quantities of the transgenic reporter constructs, 
purification of all the constructs was performed using the QIAGEN® Plasmid Plus Maxi Kit 
(QIAGEN® 12963).  In all, six constructs were prepared for microinjection:  construct with 
the zebrafish m2de1 element in forward orientation (pDr-m2de1F-cfos-EGFP), construct 
with the zebrafish m2de1 element in reverse orientation (pDr-m2de1R-cfos-EGFP), construct 
with mouse m2de1 element in forward orientation (pMm-m2de1F-cfos-EGFP), construct 
with mouse m2de1 element in reverse orientation (pMm-m2de1F-cfos-EGFP), positive 
control construct (pDest-Sox10-mCherry-Tol2CG2; graciously provided by Dr. Chi-Bin 
Chien), and the construct containing the zebrafish m2de1 element in forward orientation but 
with a potential binding site sequence mutation (pDr-m2de1F-mut-cfos-EGFP).  Cells from 
glycerol stocks for each of the six constructs were streaked onto LB + Ampicillin (100 
mg/µl) plates and incubated at 37ºC overnight; three colonies were chosen from each plate 
and used to inoculate cultures containing 3 ml LB + Ampicillin (100 mg/µl) and were grown 
8 hours with shaking at 200 RPM at 37ºC; the starter cultures were subsequently added to 
Erlenmeyer Flasks containing 500 ml LB + Ampicillin (100 mg/µl) and were grown 
overnight with shaking at 200 RPM at 37ºC.   
The plasmid DNA was then harvested following the procedure as outlined in the 
QIAGEN® Plasmid Plus Maxi Kit (QIAGEN 12963, Hilden, Germany).  One hundred ml of 
culture were pelleted at 6000 x g for 15 minutes at 4ºC and the supernatant was discarded; 
the pelleted bacteria cells were resuspended in 5 ml of Buffer P1 by pipetting up and down 
until no clumps were visible; 5 ml Buffer P2 was added to the mixture and gently mixed by 
inversion until viscous; the viscous mixture was incubated at room temperature for 3 
minutes; 5 ml of Buffer S3 was added to the mixture and mixed by inverting six times; 
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immediately, the mixture was transferred to the QIAfilterTM Maxi Cartridge and incubated at 
room temperature for 10 minutes; during the incubation, a QIAGEN® Plasmid Plus Maxi 
Spin Column with a Tube Extender was attached to a vacuum manifold hooked up to a 
vacuum supply source; a QIAfilterTM Plunger was inserted into the QIAfilterTM Maxi 
Cartridge and the lysate was filtered into a new tube; 5 ml Buffer BB was added to the 
cleared lysate and was mixed by inverting six times; the lysate was transferred to the 
QIAGEN® Plasmid Plus Maxi Spin Column with a Tube Extender attached to the vacuum 
manifold; the vacuum source was turned on drawing the liquid through the column; the 
vacuum source was turned off once all the liquid had been drawn through; 0.7 ml Buffer 
ETR was added to the QIAGEN® Plasmid Plus Maxi Spin Column with a Tube Extender 
attached to the vacuum manifold;  the vacuum source was turned on drawing the liquid 
through the column; the vacuum source was turned off once all the liquid had been drawn 
through; 0.7 ml Buffer PE was added to the QIAGEN® Plasmid Plus Maxi Spin Column 
with a Tube Extender attached to the vacuum manifold;  the vacuum source was turned on 
drawing the liquid through the column; the vacuum source was turned off once all the liquid 
had been drawn through; the QIAGEN® Plasmid Plus Maxi Spin Column was removed from 
the vacuum source and centrifuged in a microcentrifuge at 10000 x g for 1 minute with the 
excess liquid being discarded;  the QIAGEN® Plasmid Plus Maxi Spin Column was placed 
into a 1.5 ml microcentrifuge tube; 400 µl Nuclease-Free Water was added to the center of 
the QIAGEN® Plasmid Plus Maxi Spin Column and incubated for 2 minutes; the mixture 
was centrifuged for 1 minute at 10000 x g; the supernatant containing the transgenic reporter 
construct was separated into five 1.5 ml microcentrifuge tubes and placed in the -20ºC 
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freezer.  The concentrations of the prepared transgenic reporter constructs were quantified by 
NanoDrop® ND-1000 spectrophotometry.        
Making Transposase mRNA 
 The transposase mRNA utilized in the microinjection process was created from 
glycerol stock DNA graciously provided by Dr. Chi-Bin Chien.  Cells from glycerol stocks 
containing pCS2FA Tol2 transposase plasmid were streaked onto LB + Ampicillin (100 
mg/µl) plates and incubated at 37ºC overnight; two colonies were chosen from each plate and 
used to inoculate cultures containing 3 ml LB + Ampicillin (100 mg/µl) and were grown 8 
hours with shaking at 200 RPM at 37ºC; the starter culture with the most growth was 
subsequently added to Erlenmeyer Flasks containing 500 ml LB + Ampicillin (100 mg/µl) 
and were grown overnight with shaking at 200 RPM at 37ºC.  The plasmid DNA was then 
harvested following the procedure as outlined previously within the QIAGEN® Plasmid Plus 
Maxi Kit (QIAGEN 12963).  After the concentrations of the prepared pCS2FA Tol2 
transposase plasmid were quantified by NanoDrop® ND-1000 spectrophotometry, the DNA 
template was linearized for transcription via digestion with the NotI restriction enzyme (NEB 
R0189S) at 37ºC overnight [15.0 µl pCS2FA plasmid DNA (20 µg), 10.0 µl 10X Buffer 3 
(NEB), 1.0 µl BSA, 8.0 µl NOTI (NEB R0189S), and 66.0 µl DEPC water].  After complete 
digestion, the NotI enzyme was heat killed by incubating the solution in a heating block at 
65ºC for 25 minutes.  The now linearized plasmid was purified using the Wizard® SV Gel 
and PCR Clean-Up System (Promega TB308) as described previously.  The concentration of 
the linearized pCS2FA Tol2 transposase plasmid were quantified by NanoDrop® ND-1000 
spectrophotometry, and 2.0 µl plasmid was also run on a 1% agarose TBE gel containing 
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ethidium bromide (0.3 µg/ml) set at 115 Volts for 1 hour and 10 minutes.  This was done to 
insure that complete digestion had occurred.     
 The linearized pCS2FA Tol2 transposase template was then transcribed using the 
mMESSAGE mMACHINE® SP6 RNA Transcription Kit (Ambion® AM1340M, Garden 
Island, NY).  The 10X Reaction Buffer, the 2X NTP/CAP, and the Enzyme Mix were spun 
briefly to remove RNases; the Enzyme Mix was placed on ice, while the 10X Reaction 
Buffer and the 2X NTP/CAP were thawed at room temperature;  once thawed, the 10X 
Reaction Buffer and the 2X NTP/CAP were vortexed to insure that any solid particles were 
completely dissolved; the 10X Reaction Buffer was then kept at room temperature while the 
2X NTP/CAP was placed on the ice; the transcription reaction was then assembled in a 1.5 
ml microcentrifuge tube:  4.73 µl DEPC water, 1.27 µl pCS2FA Tol2 transposase DNA (1 
µg), 10.0 µl 2X NTP/CAP, 2.0 µl 10X Reaction Buffer, and 2.0 µl Enzyme Mix; the reaction 
was mixed by gently flicking the tube, spun briefly to pellet the reaction, and incubated at in 
37ºC water bath for 2 hours; after the incubation, 1.0 µl of TURBO DNase was added to the 
reaction, the reaction was mixed well, and then incubated at 37ºC for 15 minutes; 30 µl of 
DEPC water and 30 µl of LiCl Precipitation Solution were added, the reaction was mixed 
well, and then precipitated at -20ºC for 1 hour; after the precipitation, the reaction was 
centrifuged at 4ºC for 15 minutes at maximum speed; the supernatant was removed and 1 ml 
of 75% ethanol was added; the reaction was spun at 4ºC for 10 minutes at maximum speed; 
the supernatant was removed and the tube was inverted over a paper towel for 30 minutes to 
insure complete removal of the supernatant; the resulting pellet was resuspended in 20 µl of 
DEPC water; the mRNA was diluted to 125 ng/µl and aliquoted into fifteen 10 µl aliquots; 
mRNA was subsequently stored at -20ºC.  The concentration of the pCS2FA Tol2 
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transposase mRNA was quantified by NanoDrop® ND-1000 spectrophotometry, and 2.0 µl 
mRNA was also run on a 1% agarose TBE gel containing ethidium bromide (0.3 µg/ml) set 
at 115 Volts for 1 hour and 5 minutes to make sure that the mRNA was the appropriate size. 
Microinjections 
 In order to obtain embryos for microinjection, fish were allowed to mate for 30 
minutes as previously described.  The 1-2 cell embryos were washed using RO water from a 
squirt bottle, and placed into a large glass dish with 1X Danieau Buffer (58 mM NaCl, 0.7 
mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5 mM HEPES pH 7.6).  Embryos for 
microinjection needed to be within the 1-2 cell stages. 
During the 30 minutes that the zebrafish were mating, the microinjection solution was 
prepared (125 ng transgenic reporter construct, 175 ng pCS2FA Tol2 transposase mRNA, 2.0 
µl 0.5% Phenol Red (Sigma P0290), and RNase-free water to a final solution volume of 5.0 
µl).  The needles utilized during the microinjection process were also constructed during this 
time.  The microinjection needles were created using a David Kopf Instruments Vertical 
Pipette Puller (Model 700C) with its heat set at 54 and its solenoid set at 10, and RNase free 
3.5 nanoliter (nl) capillary tubes (World Precision Instruments 4878).  The 3.5 nl capillary 
tubes were baked prior to pulling at 260ºC to inactivate RNases and were pulled so that they 
had an average taper and an outer diameter of approximately 8 micrometers (µm).  The 
injection solution was kept on ice prior to injection. 
 Microinjections were executed using the Nanoliter 2000 Microinjector (World 
Precision Instruments Model B203XVY) housed on a Marhauser MMJR Micromanipulator 
(World Precision Instruments).  Using watchmaker forceps (size 5), the tips of the injection 
needles were broken so that the needle tip was beveled.  One needle was then filled with 
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mineral oil and mounted onto the Nanoliter 2000 Microinjector.  The mineral oil was 
expelled so that approximately one-fifth of the needle still contained oil.  This process was 
executed via the metal pushrod which extended from the microinjector apparatus into the 
needle mounted onto the machine itself.  The needle was then filled with microinjection 
injection solution by drawing the metal pushrod back into the Nanoliter 2000 Microinjector, 
thus producing a needle ready for use inside of which, the microinjection solution was 
separated from the metal pushrod by a buffering, inert layer of incompressible mineral oil.   
 Next, embryos retrieved from crosses described previously were prepared for 
microinjection.  An injection stage was made previously by taping a 1.0 millimeter thick 
VWR micro slide (VWR International 48300-025) onto the bottom of a small, plastic Petri 
dish.  Approximately 50 zebrafish embryos at the 1-2 cells stages were placed onto the Petri 
dish so that they rested against the lip of the micro slide.  This positioning not only kept the 
embryos lined up for more efficient injection, but also provided a backing support for the 
embryos during the actual injection process.  The injection stage was put under a dissecting 
microscope and the injection needle was positioned at a 25º incline so that it was possible to 
observe the stage, embryos, and injection needle through the eyepiece.  The stage was moved 
so that the tip of the needle pierced through a single embryo’s chorion, passed through the 
yolk sac, and came to rest just under the blastomeres.  The Nanoliter 2000 Microinjector was 
then used to inject 4 nl of the desired microinjection solution into the embryo’s yolk sac.  The 
dark red coloration of the 0.5% Phenol Red made it relatively easy to determine if the 
solution actually entered the yolk sac or the space surrounding the embryo.  The needle was 
then removed from the embryo by backing the injection stage away from the needle, 
completing the process of microinjecting a single zebrafish embryo.  This process was 
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repeated for all of the embryos positioned on the injection stage, after which another 
selection of 50 embryos were collected and placed onto the stage for a second round of 
injections.  Generally, two rounds of injections, approximately 100 embryos, were all that 
could be injected in a single sitting due to the rapid pace of zebrafish embryonic 
development. 
 After microinjection, the embryos were placed in a large glass bowl filled with fresh 
1X Danieau Buffer, and placed into a VWR Mini Incubator (VWR International 97025-630) 
set at 27ºC.  Careful attention was paid to the embryos to insure they continued to develop 
properly and that the number of casualties was kept at a minimum.  Two to three times daily, 
the embryos were removed from the incubator, the dead embryos and those possessing 
developmental malformations were removed, and fresh 1X Danieau Buffer was added.  This 
process was carried out daily until the embryos had reached 48 or 54 hours post fertilization 
depending on the injected construct and the time of desired imaging.  Some embryos injected 
with the pDr-m2de1F-cfos-EGFP construct were raised to adulthood to establish stable 
transgenic lines. 
This particular study was centered on the process of microinjections and throughout 
the course of the project numerous problems were encountered and troubleshooting was a 
must.  The first predicament faced was that, during the microinjection process, approximately 
40% of the embryos died upon or right after actual injection.  It has been reported that when 
utilizing the Tol2 system, along with enhancer containing reporter constructs in zebrafish, 
only a 10-20% success rate can be expected when looking for reporter gene expression 
(Fisher et al., 2006).  Thus, the high death rates upon microinjection were only making it that 
much more difficult to retrieve successful, transgenic embryos.  Repetition of the 
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microinjection process allowed for practice of the actual injection technique making it 
increasingly easy to inject the 1-2 cell embryos in the center of the yolk, just below the 
blastomeres.  It is in this region that the literature instructs the solution to be deposited for the 
highest chances of successful transgenic element insertion (Fisher et al., 2006).  It also 
became evident that modifying the injection needles was necessary.  When the 
microinjections were first started, the needles used had a rather sharp taper and a somewhat 
large width, thus making it difficult to pierce the chorions of the embryos without bursting 
the embryo itself.  It was decided to change the settings on the David Kopf Instruments 
Vertical Pipette Puller (Model 700C).  The heat was decreased from 85 to 54 and the 
solenoid was increased from 0 to 10 in the hope of making the pulling process more gradual, 
thereby stretching the glass pipette to give a longer taper and smaller needle width.  After 
doing so, the embryo survival rate jumped from 60% to approximately 90%.   
Another major problem arose when, upon completion and analysis of the first several 
rounds of injections involving the m2de1 containing reporter constructs, no EGFP expression 
was seen in the transgenic embryos.  It was decided that the transposase mRNA needed to be 
handled much more carefully as mRNA is a very delicate molecule susceptible to 
degradation from various RNases (Alberts, 2008).  Without proper handling and care, the 
transposase mRNA was probably degrading, which in turn disallowed the insertion of the 
m2de1 element into the zebrafish genome.  Upon careful consideration, it was determined 
that it would be beneficial to bake the 3.5 nl capillary tubes (World Precision Instruments 
4878) in an oven at 260ºC overnight to destroy any residual RNases present in the tubes prior 
to pulling.  This single step kept the mRNA intact, and soon after EGFP expression was 
noted. 
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Immobilization of Transgenic Embryos 
Once the remaining injected embryos reached the desired developmental stage, they 
were then immobilized and positioned for viewing using laser scanning confocal microscopy.  
A way in which to position the embryos in the orientation needed to best reveal the EGFP 
expression, but at the same time keep them alive so as to not degrade the EGFP, was soon 
devised using a Tricaine solution to anesthetize the embryos and an agarose solution to 
further immobilize and position the embryos.    Injected embryos were placed under a 
dissecting microscope, and were dechorionated using watchmaker forceps.  At 48 and 54 
hours post fertilization, many of the embryos had shed their chorions as part of their natural 
developmental process.  Dechorionated embryos were placed into a 1.5 ml microcentrifuge 
tube along with 0.5 mL of the 1X Danieau Buffer.  A solution of 1X Danieau Buffer + 0.4% 
Tricaine (Sigma-Aldrich Life Science A5040) was added to anesthetize the embryos.  The 
injected zebrafish were exposed to the 1X Danieau Buffer + 0.4% Tricaine solution for 
approximately 5 minutes or until no visible voluntary movements were observed from the 
zebrafish embryo.  At first, a 1X Danieau Buffer + 0.016% Tricaine (Sigma-Aldrich Life 
Science A5040) solution was implemented, but this concentration was too low to 
successfully anesthetize the embryos.  After gradually increasing the concentration over 
multiple trials, it was concluded that a 1X Danieau Buffer + 0.4% Tricaine (Sigma-Aldrich 
Life Science A5040) solution worked best to anesthetize the zebrafish. 
A solution of 1X Danieau Buffer + 0.8% GenePure LE Agarose (ISC BioExpress 
C404595) was then melted.  Using a disposable glass pipette, 0.25 mL of the melted agarose 
solution was placed into a 1.5 ml microcentrifuge tube.  Before the agarose solidified, one of 
the anesthetized, injected embryos was placed into the 1.5 ml microcentrifuge tube 
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containing the agar.  The embryo, along with a sizable amount of the melted agarose 
solution, was removed from the microcentrifuge tube using a disposable glass pipette and 
deposited into the well of a deep-welled, VWR Culture Slide (VWR International 48327-
000).  The embryo was positioned in the desired orientation within the slide prior to the 
agarose solidifying.  At first, a 1X Danieau Buffer + 0.4% GenePure LE Agarose (ISC 
BioExpress C404595) solution was used to set the anesthetized embryos into the deep welled 
slides for confocal imagery.  However, such a low concentration of agarose did not fully set 
and made it difficult to keep the embryos in the orientation wanted for imaging.  The agarose 
concentration was gradually increased as well and it was found that a 1X Danieau Buffer + 
0.8% GenePure LE Agarose (ISC BioExpress C404595) solution worked best to set the 
embryos. 
Generally, two orientations were utilized for viewing the embryos:  a dorsal (top-
down) orientation in which the upper portion of the zebrafish head was visible, and a sagittal 
orientation in which the lateral areas of the zebrafish head could be analyzed.  This whole 
process was repeated for approximately six to eight of the injected, anesthetized embryos.  
Once the agarose solution had solidified around the embryos, a disposable glass pipette was 
used to add a few drops of 1X Danieau Buffer to the wells, and a Corning Cover Glass #1 
(Corning Life Sciences 2845-18) slip was added over the tops of the wells. 
Imaging Transgenic Embryos 
 The embryos were viewed for reporter gene expression using a Zeiss LSM 510 
Confocal Microscope.  Slides were positioned one at a time under the microscope and 
examined using the 10X objective, the Argon laser, and the FITC filter to image the 
localization and positioning of EGFP expression within the developing zebrafish embryos.  If 
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an embryo showed EGFP expression, a Z-Stack was taken of that particular embryo in the 
hopes of imaging all layers and depth of the reporter gene expression.  The Z-Stack was 
generally set at an average of 15 slices of approximately 8 µm thickness, a scan speed of 2, 
and a pixel quality of 1024 X 1024.  The Z-Stacks were then modified using Zeiss software’s 
built in Projection Tool in order to overlay each image slice on top of each other to give a 
composite image for each embryo. 
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RESULTS 
Zebrafish and Mouse HCNE Isolation from Genomic DNA  
 The identified m2de1 element found in zebrafish was isolated from total genomic 
DNA through Polymerase Chain Reaction (PCR) amplification.  The two sequence and 
species specific primers (Table 1) used for the PCR protocol were designed so that they 
flanked the chosen portion of the m2de1 sequence within the zebrafish genome (Fig. 2).  The 
PCR reaction was predicted to produce a PCR product of around 450 nucleotides in length, 
which is many nucleotides longer than the previously identified 260 base pairs of the m2de1 
element that were highly conserved (Fig. 6).  This was by design as the primers were 
constructed to amplify extended regions adjacent to the core m2de1 element to ensure 
isolation of the areas potentially possessing cis-regulatory function.  Upon successful 
isolation from the zebrafish genome, the m2de1 element was used for cloning the sequence 
into the pCR®2.1-TOPO® TA cloning vector.  The isolation and amplification of the 
identified m2de1 element found in the mouse genome was done as previously described 
(Nelson, 2011). 
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Fig. 6.  Isolation of the zebrafish m2de1 element from genomic DNA.  Gel electrophoresis 
was performed to insure correct and sufficient amplification of the m2de1 element.  Lane 1 
contains 100 base pair ladder (NEB N3231L).  Lanes 2, 3, and 4 contain control samples.  
Lane 5 contains the m2de1 element PCR product.  The arrow points to the approximately 440 
nucleotide long element, indicating successful isolation. 
 
HCNE TOPO® TA Cloning® 
 The isolated m2de1 elements from zebrafish and mouse were then cloned into the 
pCR®2.1-TOPO® cloning vector creating the Dr-m2de1-pCR2.1-TOPO vector and the Mm-
m2de1-pCR2.1-TOPO vector, respectively, as previously described (Nelson, 2011).  This 
particular process was carried out for both the zebrafish and mouse HCNEs following 
standard Invitrogen TOPO TA Cloning® protocol (Invitrogen 45-0641).  The Dr-m2de1-
pCR2.1-TOPO (Fig. 7A) and the Mm-m2de1-pCR2.1-TOPO (Fig. 7B) clones were grown up 
and used for the subsequent construction of transgenic constructs. 
1 2 3 4 5 
500 bp 
400 bp 
450 bp 
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Fig. 7.  Cloning the zebrafish and mouse m2de1 elements into pCR®2.1-TOPO®.  Above 
are schematic diagrams depicting the Dr-m2de1-pCR2.1-TOPO vector (A) and the Mm-
m2de1-pCR2.1-TOPO vector (B) after successful Invitrogen TOPO TA Cloning® protocol 
(Invitrogen 45-0641).  The EcoRI sites which flank the m2de1 elements, the BglII sites, and 
the attB1 and attB2 sites are shown for both vectors.  The generation of both vectors was 
done previously (Nelson, 2011).  
 
Isolating HCNEs from pCR®2.1-TOPO® 
 The development of the reporter constructs containing the transgenic expression 
cassettes was done using Gateway® Technology’s Cloning System.  As stated previously, 
the construction of the vectors was the result of a two-part subcloning process where the 
m2de1 element was subcloned into the pDONR221 vector and then the pGW_cfosEGFP 
vector.  In total, four sets of reporter constructs were created:  construct with the zebrafish 
m2de1 element in forward orientation (pDr-m2de1F-cfos-EGFP), construct with the 
zebrafish m2de1 element in reverse orientation (pDr-m2de1R-cfos-EGFP), construct with 
mouse m2de1 element in forward orientation (pMm-m2de1F-cfos-EGFP), and construct with 
mouse m2de1 element in reverse orientation (pMm-m2de1R-cfos-EGFP).  I was responsible 
for preparing the zebrafish m2de1 element for reverse orientation insertion.  The preparation 
of the zebrafish m2de1 element for forward orientation insertion, the mouse m2de1 element 
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for forward orientation insertion, and the mouse m2de1 element for reverse orientation 
insertion were done previously by a member of the Zerucha lab (Nelson, 2011).   
In order to produce the transgenic reporter construct containing the zebrafish m2de1 
element in its reverse orientation, the zebrafish element was first isolated out of the Dr-
m2de1-pCR2.1-TOPO (Fig. 7A) plasmid and prepared for reverse orientation insertion by 
PCR using the primer set 5'-attB2-TOPO and 3'-attB1-TOPO (Table 1).  The PCR product 
was predicted to be 528 nucleotides in length due to the addition of the attB1 and attB2 sites, 
which is what was observed (Fig. 8).  The PCR product was subsequently cleaned for 
utilization in the BP reaction.  
 
Fig. 8.  Isolating the zebrafish m2de1 element out of Dr-m2de1-pCR2.1-TOPO.  Gel 
electrophoresis was performed to determine if the zebrafish m2de1 element was successfully 
isolated from the Dr-m2de1-pCR2.1-TOPO vector for subsequent insertion into the 
pDONR221 donor plasmid (Fig. 7A).  Lane 1 contains 100 base pair ladder (NEB N3231L).  
Lanes 2 contains the m2de1 element PCR product post isolation with the flanking attB1 and 
attB2 sites.  The arrow points to the 528 nucleotide long element, indicating successful 
isolation.  
 
Construction of Middle Entry Vectors 
Next, the zebrafish m2de1 element was inserted in its reverse orientation into the 
previously mentioned donor plasmid, pDONR221 in a process known as the BP reaction 
1517 bp 
1000 bp 
500 bp 
400 bp 
528 bp 
1 2 
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(Fig. 4).  As mentioned previously, the BP reaction utilizes Gateway® BP ClonaseTM II 
Enzyme Mix (Invitrogen 865071) and enzyme assisted recombination to construct middle 
entry vectors.  The resulting middle entry vector containing the zebrafish HCNE in its 
reverse orientation was named pME-Dr-m2de1R.  I was responsible for preparing the middle 
entry vector containing the zebrafish m2de1 element in its reverse orientation (pME-Dr-
m2de1R).  The preparation of the middle entry vector containing the zebrafish m2de1 
element in its forward orientation (pME-Dr-m2de1F), the middle entry vector containing the 
mouse m2de1 element in its forward orientation (pME-Mm-m2de1F), and the middle entry 
vector containing the mouse m2de1 element in its reverse orientation (pME-Mm-m2de1R) 
was done by a previous member of the Zerucha lab (Nelson, 2011).   
After the BP reaction had been completed, the reaction was then transformed into 
chemically competent DH5α E. coli and grown on LB + Kanamycin (50 mg/μl) plates.  The 
ccdB gene found within the pDONR221 donor plasmid was removed upon successful 
insertion of the reverse oriented zebrafish m2de1 element into the donor plasmid due to BP 
reaction recombination (Fig. 2).  The ccdB gene serves as an intracellular control element by 
killing cells that lack resistance to its resultant protein.  The DH5α E. coli cells that the BP 
reaction was transformed into lack ccdB resistance meaning that any bacterial colonies that 
grew would have successfully undergone recombination and ccdB gene removal.  Colonies 
were grown up in cultures containing 3 ml LB + Kanamycin (50 mg/µl), prepared via 
miniprep, and examined using BglII and EcoRI restriction digestion analysis.  Both the Dr-
m2de1-pCR2.1-TOPO (Fig. 7A) and pME-Dr-m2de1R (Fig. 9B) plasmids have Kanamycin 
resistance, necessitating the screening of the pME-Dr-m2de1R with the two different 
restriction enzymes to rule out the possibility of residual Dr-m2de1-pCR2.1-TOPO 
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background transformation.   The Dr-m2de1-pCR2.1-TOPO construct contains 1 BglII site 
and 2 EcoRI sites (Fig. 7A).  The pME-Dr-m2de1R construct contains two EcoRI sites (Fig. 
9B).  If the Dr-m2de1-pCR2.1-TOPO construct is present, restriction digestion will result in 
three bands of 2931 base pairs, 982 base pairs, and 457 base pairs.  If the correct middle 
entry vector, pME-Dr-m2de1R, is present, two bands of 2656 base pairs and 457 base pairs 
will be seen as the construct does not contain the BglII site.  Gel electrophoresis analysis of 
the restriction digest showed a band in lane 1 of 457 base pairs but no band of 982 base pairs 
(Fig. 10), indicating that the desired plasmid, pME-Dr-m2de1R, had been constructed.   
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Fig. 9.  Constructing middle entry vectors for the mouse and zebrafish m2de1 elements.  
Above are schematic diagrams depicting the pME-Dr-m2de1F construct (A), the pME-Dr-
m2de1R construct (B), the pME-Mm-m2de1F construct (C), and the pME-Mm-m2de1R 
construct (D) after successful BP reaction.  The EcoRI sites which flank the m2de1 elements 
and the attL1 and attL2 sites are shown for the constructs.  
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Fig. 10.  Gel electrophoresis analysis of the pME-Dr-m2de1R restriction digest.  Gel 
electrophoresis was performed to determine if the BP reaction was successful in creating the 
pME-Dr-m2de1R construct (Fig. 9B).  Lane 1 contains pME-Dr-m2de1R plasmid cut with 
EcoRI (NEB R0101S) and BglII (NEB R0144S), testing for successful translocation.  Lane 2 
contains 100 base pair ladder (NEB N3231L).  The arrow points to the 457 base pair long 
m2de1 fragment.  The lack of a 982 base pair fragment indicates the lack of a BglII site 
meaning only the correct middle entry vector, pME-Dr-m2de1R, was formed.  
 
 
Construction of Transgenic Reporter Constructs 
Next, the middle entry plasmid was used to relocate the reverse oriented zebrafish 
m2de1 element into the previously mentioned destination vector, pGW_cfosEGFP, in a 
process known as the LR reaction (Fig. 5).  The LR reaction utilizes Gateway® LR 
ClonaseTM II Plus Enzyme Mix (Invitrogen 12538120) and enzyme assisted recombination to 
construct transgenic reporter constructs.  The resulting reporter construct containing the 
zebrafish HCNE in its reverse orientation was named pDr-m2de1R-cfos-EGFP.  I was 
responsible for preparing the reporter construct containing the zebrafish m2de1 element in its 
reverse orientation (pDr-m2de1R-cfos-EGFP).  The preparation of the reporter constructs 
containing the zebrafish m2de1 element in its forward orientation (pDr-m2de1F-cfos-EGFP), 
the reporter constructs containing the mouse m2de1 element in its forward orientation (pMm-
m2de1F-cfos-EGFP), and the reporter constructs containing the mouse m2de1 element in its 
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reverse orientation (pMm-m2de1R-cfos-EGFP) was done by a previous member of the 
Zerucha lab (Nelson, 2011).  All the reporter constructs contain the expression cassette 
(m2de1 element upstream from the minimal cfos promoter and the reporter gene, EGFP) 
flanked by Tol2 recognition sites. 
After the LR reaction had been completed, the reaction was then transformed into 
One Shot® TOP10 Chemically Competent E. coli (Invitrogen C4040-10) and grown on LB + 
Ampicillin (100 mg/μl) plates.  As shown earlier, the pME-Dr-m2de1R vector has 
Kanamycin resistance (Fig. 9B) while the pDr-m2de1R-cfos-EGFP construct has Ampicillin 
resistance (Fig. 11B).  Any bacterial colony that grew on the LB + Ampicillin (100 mg/μl) 
plates should be the reporter construct and not the middle entry vector.  Furthermore, the 
ccdB gene found within the pDONR221 donor plasmid was removed upon successful 
insertion of the reverse oriented zebrafish m2de1 element into the donor plasmid due to BP 
reaction recombination (Fig. 3).  The One Shot® TOP10 Chemically Competent E. coli 
(Invitrogen C4040-10) cells that the LR reaction was transformed into lack ccdB resistance 
meaning that any bacterial colonies that grew would have successfully undergone 
recombination and ccdB gene removal.  Colonies were grown up in cultures containing 3 ml 
LB + Ampicillin (100 mg/µl), prepared via miniprep, and examined using EcoRI restriction 
digestion analysis.  The pME-Dr-m2de1R middle entry construct contains two EcoRI sites 
(Fig. 9B).  The pDr-m2de1R-cfos-EGFP reporter construct contains two EcoRI sites as well 
(Fig. 11B).  If the pME-Dr-m2de1R middle entry construct is present, restriction digestion 
will result in two bands of 2656 base pairs and 457 base pairs.  If the correct reporter 
construct, pDr-m2de1R-cfos-EGFP, is present, two bands of 7484 base pairs and 457 base 
pairs will be seen.  Therefore, although both constructs contain the same restriction sites, the 
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large variation in size between the top bands that are formed with restriction should make it 
possible to determine if the LR reaction was successful.  Gel electrophoresis analysis of the 
restriction digest showed two bands in lane 2 of 7484 base pairs and 457 base pairs (Fig. 12), 
indicating that the desired reporter construct, pDr-m2de1R-cfos-EGFP, had been constructed. 
 
Fig. 11.  Constructing the reporter constructs for the mouse and zebrafish m2de1 elements.  
Above are schematic diagrams depicting the pDr-m2de1F-cfos-EGFP construct (A), the pDr-
m2de1F-cfos-EGFP construct (B), the pMm-m2de1F-cfos-EGFP construct (C), and the 
pMm-m2de1R-cfos-EGFP construct (D) after successful LR reaction.  The EcoRI sites which 
flank the m2de1 elements, the attR1 and attR2 sites, the minimal cfos promoter, the Tol2 
sites, and the EGFP gene are shown for the constructs. 
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Fig. 12.  Gel electrophoresis analysis of the pDr-m2de1R-cfos-EGFP restriction digest.  Gel 
electrophoresis was performed to determine if the LR reaction was successful in creating the 
pDr-m2de1R-cfos-EGFP construct (Fig. 11B).  Lane 1 contains 1 Kb base pair ladder (NEB 
N3232L).  Lane 2 contains pDr-m2de1R-cfos-EGFP construct cut with EcoRI (NEB 
R0101S), testing for successful translocation.  The arrow points to the 457 base pair long 
m2de1 fragment and the larger 7484 base pair long fragment.  The correct size of both bands 
indicates that the transgenic reporter construct, pDr-m2de1R-cfos-EGFP, was formed.  
 
Sequencing Results 
As mentioned throughout the Materials and Methods section, several of the constructs 
were sequenced during the course of vector construction to ensure that random point 
mutations had not occurred to the m2de1 element itself.  By definition, cis-regulatory 
elements are conserved and changes to their sequence could very well alter function.  In all, 
three different constructs were sent off for m2de1 sequencing at various stages in transgenic 
reporter construct development.  The zebrafish m2de1 element was sequenced after being 
amplified from the zebrafish genomic DNA [performed by Cornell University’s Life 
Sciences Core Laboratories using the Dr-m2de1-3 and Dr-m2de1-5b primers (Table 1)].  The 
pCR®2.1-TOPO® cloning vector containing the zebrafish m2de1 element was sequenced 
[performed by Cornell University’s Life Sciences Core Laboratories using universal M13 
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Forward and M13 Reverse primers (Table 1)].  Lastly, the pDr-m2de1F-cfos-EGFP construct 
was sequenced as well [performed by Cornell University’s Life Sciences Core Laboratories 
using the Dr-m2de1-3 and Dr-m2de1-5b primers (Table 1)]. 
 The sequencing analysis of the three separate constructs revealed that two individual 
nucleotides within the m2de1 element are different than in the published zebrafish genome 
(Fig. 13).  In one case, a cytosine was identified as a thymine (Fig. 13).  In the other case, a 
guanine was identified as an adenine (Fig. 13).  All the sequencing analyses support this case 
as all three sequenced constructs not only contained nucleotide differences in the exact same 
locations within the m2de1 sequence, but all three constructs possessed the exact same 
nucleotides in those positions as well. 
 
Fig. 13.  Summary of sequencing analysis resulting in a corrected m2de1 sequence.  Areas 
highlighted in red represent the 260 base pairs of sequence that most likely possess cis-
regulatory function and show the highest amount of sequence conservation.  The area 
highlighted in purple is the Hox binding site which was not seen in the element used by 
Parker and was subsequently mutated (Parker et al., 2011).  The 2 nucleotides highlighted in 
green represent the 2 nucleotides that form the boundaries for the m2de1 element used in our 
vector construction as shown previously (Fig. 2).  The nucleotide highlighted in yellow is the 
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cytosine that was miscalled as a thymine in the published sequence.  The nucleotide 
highlighted in blue is the guanine that was miscalled as an adenine in the published sequence.    
 
Mutation of a Potential Hox Binding Site 
In order to detail the effects of a potential Hox binding site, TAAT (Fig. 5) within the 
zebrafish m2de1 element, PCR mutagenesis was performed using the QuikChange® II XL 
Site-Directed Mutagenesis Kit (Stratagene #200521) to create the pDr-m2de1F-mut-cfos-
EGFP reporter construct.  Previous research demonstrated that a sequence similar to m2de1 
drives Meis2 expression (Parker et al., 2011).  Sequence comparison between the zebrafish 
m2de1 element and the cis-regulatory element utilized by Parker et al. revealed that the 
m2de1 element included an additional Hox binding site not used by Parker; the previously 
mentioned TAAT sequence (Fig. 14).  By eradicating this Hox binding site, it would then be 
possible to compare expression profiles driven by the two different elements.  The objective 
was to mutate the Hox binding site (TAAT) into a radically different sequence (TCGA) 
believed to possess no association with Hox binding (Fig. 14).  The TCGA mutation 
sequence should eliminate any Hox binding affinity the TAAT sequence may have had.  The 
mutation primers were designed so that an additional guanine adjacent to the Hox binding 
site was mutated as well (TAATG to TCGAT).  Due to the convenient location of an adenine 
directly 5’ to the Hox binding site, the mutation introduced a ClaI restriction site (5’ 
AT▼CGAT 3’) within the zebrafish m2de1 element not seen in the original form of the 
element.  The introduction of such a restriction site makes it relatively easy to determine if in 
fact the PCR mutagenesis was successful.  
After the QuikChange® II XL Site-Directed Mutagenesis Kit mutagenesis procedure 
was carried out using the Dr-m2de1-mut-R primer (Table 2), the Dr-m2de1-mut-F primer 
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(Table 2), and the pDr-m2de1F-cfos-EGFP reporter construct retrieved from glycerol stock, 
the reaction was transformed into XL10-Gold ultracompetent (Stratagene) cells and grown 
on LB + Ampicillin (100 mg/μl) plates.  As shown earlier, the pDr-m2de1F-cfos-EGFP 
construct has Ampicillin resistance (Fig. 11A).  The mutagenesis protocol should not have 
altered the Ampicillin resistance gene meaning both the mutated (pDr-m2de1F-mut-cfos-
EGFP) and the unmutated (pDr-m2de1F-cfos-EGFP) constructs should successfully grow on 
the plates.  Additional measures were needed to confirm successful mutagenesis.  Therefore, 
colonies were grown up in cultures containing 3 ml LB + Ampicillin (100 mg/µl), prepared 
via miniprep, and examined using ClaI restriction digestion analysis.  The pDr-m2de1F-mut-
cfos-EGFP construct contains two Cla1 sites, one site present prior to mutation and another 
site introduced through successful mutation (Fig. 15).  The pDr-m2de1F-cfos-EGFP 
construct contains one ClaI site (Fig. 11A).  If the pDr-m2de1F-mut-cfos-EGFP construct 
was created, restriction digestion will result in two bands of 6700 base pairs and 1241 base 
pairs.  Restriction of the pDr-m2de1F-cfos-EGFP construct with ClaI should result in only 
one band representing the linearized construct.  Gel electrophoresis analysis of the restriction 
digest showed two bands in lane 6 of 6700 base pairs and a larger than expected band of 
1600 base pairs (Fig. 16).  However, sequencing analysis of the plasmid confirmed that the 
TAATG binding site had been changed to TCGAT and that the pDr-m2de1F-mut-cfos-EGFP 
construct had been created successfully.     
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Fig. 14.  Mutated m2de1 element within pDr-m2de1F-mut-cfos-EGFP reporter construct.  As 
indicated previously, 450 bp of sequence were isolated to analyze for cis-regulatory function.  
Areas highlighted in red represent the 260 base pairs of sequence that show the highest 
amount of sequence conservation.  The area highlighted in purple is the mutated sequence 
which once served as a potential Hox transcription factor binding site and is the binding site 
not seen in the element used by Parker and colleagues (Parker et al., 2011).  The 2 
nucleotides highlighted in green represent the 2 nucleotides that form the boundaries for the 
m2de1 element used in our vector construction as shown previously (Fig. 2).  The 2 
nucleotides highlighted in blue represent the 2 nucleotides that form the boundaries for the 
cis-regulatory element used by Parker and colleagues (Parker et al., 2011).  The positioning 
of the additional Hox binding site which was subsequently mutated to the sequence 
highlighted in purple was such that it was not included in the element utilized by Parker and 
colleagues (Parker et al., 2011).  
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Fig. 15.  Constructing the pDr-m2de1F-mut-cfos-EGFP reporter construct.  Above is a 
schematic diagram depicting the pDr-m2de1F-mut-cfos-EGFP construct after successful PCR 
mutagenesis using the QuikChange® II XL Site-Directed Mutagenesis Kit (Stratagene 
#200521).  The EcoRI sites which flank the m2de1 elements, the ClaI sites within the 
mutated zebrafish m2de1 element, the attR1 and attR2 sites, the minimal cfos promoter, and 
the EGFP gene are shown for the construct.  
 
 
 
Fig. 16.  Gel electrophoresis analysis of pDr-m2de1F-mut-cfos-EGFP restriction digest.  Gel 
electrophoresis was performed to determine if the mutagenesis procedure was successful in 
creating the pDr-m2de1F-mut-cfos-EGFP construct (Fig. 15).  Lane 1 contains uncut pDr-
m2de1F-cfos-EGFP construct and Lane 2 contains ClaI (NEB R0197S) restricted pDr-
m2de1F-cfos-EGFP construct.  Lane 3 contains 1 Kb base pair ladder (NEB N3232L) and 
Lane 4 contains 100 base pair ladder (NEB N3231L).  Lane 5 contains uncut pDr-m2de1R-
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mut-cfos-EGFP construct cut and Lane 6 contains ClaI restricted (NEB R0197S) pDr-
m2de1R-mut-cfos-EGFP construct.  The arrows point to the 6700 base pair long fragment 
and the 1600 base pair long fragment produced by the restriction analysis.  Although these 
fragment sizes are not correct, sequencing analysis proved that the mutagenesis protocol was 
successful.  
 
 
Making Transposase mRNA 
 The pCS2FA Tol2 transposase mRNA utilized in the microinjections was created 
from glycerol stock DNA graciously provided by Dr. Chi-Bin Chien (Kwan et al., 2007).  
The plasmid was first harvested with the QIAGEN® Plasmid Plus Maxi Kit (QIAGEN 
12963) and then linearized with NotI, resulting in a linear construct ready for transcription.  
The SP6 promoter would bind necessary transcriptional proteins, beginning transcription of 
the transposase template which would stop shortly after the end of the SV40 PolyA tail due 
to linearization (Fig. 17).  The linearized plasmid was then subjected to gel electrophoresis to 
insure complete NotI digestion.  The restriction digest resulted in 1 thick band of around 
6,300 base pairs in length, the size of the plasmid (Fig. 18).  The linearized pCS2FA Tol2 
transposase template was then transcribed using the mMESSAGE mMACHINE® SP6 RNA 
Transcription Kit (Ambion® AM1340M).  Once the transcription reaction had been 
completed, the mRNA product was purified and analyzed by gel electrophoresis to determine 
if the mRNA was the right size (Fig. 19).  The Tol2 transposase mRNA is 2,251 bases long, 
and the gel analysis revealed a single band of approximately that size.  However, closer 
analysis of the gel reveals a decent amount of smearing which could in fact be the result of 
mRNA degradation.  This mRNA breakdown could have occurred prior to running the gel or 
during the actual electrophoresis process.  Fortunately, the intensity of the band and 
exactness of its size indicates that transcription resulted in enough Tol2 mRNA for successful 
microinjection. 
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Fig. 17.  The pCS2FA Tol2 transposase plasmid.  Above is a schematic diagram depicting 
the pCS2FA Transposase plasmid.  The NotI site, the SP6 promoter, the transposase 
sequence, and the SV40 Poly A tail are all shown.  
 
 
 
Fig. 18.  Digestion of the pCS2FA Tol2 transposase plasmid for linearization.  After 
restriction digestion of the pCS2FA Tol2 Transposase Plasmid with NotI (NEB R0189S), gel 
electrophoresis was performed to determine if the digestion was successful.  Lane 1 contains 
1 Kb base pair ladder (NEB N3232L).  Lane 2 contains linearized pCS2FA Tol2 Transposase 
plasmid.  The arrow points to the 6300 base pair long linearized plasmid. 
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Fig. 19.  Production of pCS2FA Tol2 transposase mRNA.  After transcription of pCS2FA 
Tol2 Transposase Plasmid with the mMESSAGE mMACHINE® SP6 RNA Transcription 
Kit (Ambion® AM1340M), gel electrophoresis was performed to determine if transcription 
was successful.  Lane 1 contains ssRNA ladder (NEB N0362).  Lane 2 contains pCS2FA 
Tol2 Transposase mRNA.  The arrow points to the 2251 base pair long mRNA product. 
 
 
Transgenic Results Overview 
Microinjections were performed to determine if the m2de1 putative cis-regulatory 
element was able to direct expression of the reporter gene in a manner consistent with the 
known expression pattern of meis2a (Fig. 20).  Once microinjected into the zebrafish 
embryos, the pCS2FA Tol2 Transposase mRNA is translated into transposase protein, the 
expression cassette flanked by Tol2 recombination sites is cleaved from the reporter 
construct by Tol2 transposase and ultimately inserted into the embryos genome.  Once in the 
zebrafish genome, if in fact the m2de1 element functions as an enhancer element, the 
transcription factors bound to this element should direct the minimal cfos promoter to initiate 
transcription of the reporter gene, EGFP.  Without the binding of additional transcriptional 
proteins, the minimal promoter cannot begin transcription of the reporter gene thus 
correlating EGFP expression with element functionality.  It is believed that due to the 
proximity between the m2de1 element and the meis2a gene meis2a expression is under the 
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direction of m2de1.  Therefore, the expression pattern of EGFP should recapitulate at least a 
portion of the expression pattern of endogenous meis2a as expression of the reporter gene is 
under the influence of m2de1.  
    
Fig. 20.  Whole mount in situ hybridization for meis2a in zebrafish.  In situ hybridization 
was performed on 48 hours post fertilization zebrafish embryos to localize and define the 
expression of meis2a in a spatial and temporal manner (Carpenter, 2010).  Two orientations 
were utilized for viewing the embryos:  a dorsal (top-down) orientation in which the upper 
portion of the zebrafish head was visible (A), and a sagittal orientation in which the lateral 
areas of the zebrafish head could be analyzed (B).  The expression of meis2a was found 
throughout the forebrain (blue arrow), midbrain (red arrow), hindbrain (yellow arrow), and 
eye of the zebrafish (green arrow).       
 
A Nanoliter 2000 Microinjector (World Precision Instruments Model B203XVY) 
housed on a Marhauser MMJR Micromanipulator (World Precision Instruments) was utilized 
to inject 1-2 cell embryos with one of the six various constructs previously developed:  
positive control construct (pDest-Sox10-mCherry-Tol2CG2; graciously provided by Dr. Chi-
Bin Chien), construct with the zebrafish m2de1 element in forward orientation (pDr-m2de1F-
cfos-EGFP), construct with the zebrafish m2de1 element in reverse orientation (pDr-
A B 
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m2de1R-cfos-EGFP), construct with mouse m2de1 element in forward orientation (pMm-
m2de1F-cfos-EGFP), construct with mouse m2de1 element in reverse orientation (pMm-
m2de1F-cfos-EGFP), and the construct containing the zebrafish m2de1 element in forward 
orientation but with a putative Hox  binding site sequence mutation (pDr-m2de1F-mut-cfos-
EGFP).  The embryos were injected at the 1-2 cell stage to ensure the presence of the 
expression cassette in all subsequently produced cells.  
Expression Directed by the Positive Control Construct 
The pDest-Sox10-mCherry-Tol2CG2 positive control construct has a known 
expression pattern in which EGFP is expressed in the heart of developing zebrafish embryos 
most notably at 24 hours post fertilization.  The positive control construct also directs the 
expression of mCherry within the neural crest of developing embryos but this expression was 
not analyzed.  Using a positive control construct allowed troubleshooting, practice of the 
microinjection technique, and the elimination of experimental variables to be carried out.  A 
total of 463 embryos were injected with the positive control construct and analyzed for EGFP 
expression using the Zeiss LSM 510 Confocal Microscope.  Fifteen of the 463 embryos 
exhibited reporter gene expression.  As expected, EGFP expression was seen in the 
developing hearts of the zebrafish embryos (Fig. 21).  This was a good indication that 
injection of the experimental constructs could ensue.  
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Fig. 21.  pDest-Sox10-mCherry-Tol2CG2 positive control reporter gene expression.  EGFP 
expression is localized in the heart of 24 hours post fertilization zebrafish embryos 
previously injected with pDest-Sox10-mCherry-Tol2CG2 positive control construct.  During 
the process of injecting the positive control construct, the immobilization technique was 
perfected.  Embryos that were not anesthetized displayed a great deal of movement that 
impacted the quality of the confocal images (A).  Embryos that were anesthetized displayed 
no movement which made positioning the embryos for confocal imagery much easier (B).  
The red arrows point to the developing zebrafish hearts showing abundant EGFP expression.  
The blue arrows point to the areas in which the head of the embryo would be found.  The 
yellow arrows point to the areas in which the tail of the embryo would be found.  The orange 
arrows point to the yolk sac. 
 
Expression Directed by the Zebrafish m2de1 Element 
The pDr-m2de1F-cfos-EGFP construct contains the zebrafish m2de1 element in its 
forward orientation.  A total of 60 embryos were imaged for EGFP expression at 48 hours 
post fertilization using the Zeiss LSM 510 Confocal Microscope after injection with the pDr-
m2de1F-cfos-EGFP construct.  Fourteen of these injected embryos displayed reporter gene 
expression.  Furthermore, 147 embryos were retrieved from crosses involving zebrafish 
previously injected with the pDr-m2de1F-cfos-EGFP construct and raised to adulthood to 
establish stable transgenic lines.  In total, 100 of these 147 embryos exhibited reporter gene 
expression.  As expected, EGFP expression was seen in anterior regions of the zebrafish 
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embryos (Fig. 22) mirroring endogenous meis2a expression (Fig. 20).  More specifically, 
reporter gene expression appears to be located within the midbrain, neurons of the midbrain, 
portions of the hindbrain, as well as the tectum (Fig. 22).  Little to no EGFP expression was 
seen in the developing eyes of the embryos (Fig. 22).   
 
 
Fig. 22.  pDr-m2de1F-cfos-EGFP reporter gene expression.  The images above depict EGFP 
expression localization in 48 hours post fertilization zebrafish embryos previously injected 
with pDr-m2de1F-cfos-EGFP construct.  Two orientations were utilized for viewing the 
embryos:  a dorsal (top-down) orientation in which the upper portion of the zebrafish head 
was visible (A), and a sagittal orientation in which the lateral areas of the zebrafish head 
could be analyzed (B).  The expression of EGFP was found throughout the midbrain (blue 
arrow), portions of the hindbrain (red arrow), and tectum (yellow arrow). 
 
The pDr-m2de1R-cfos-EGFP construct contains the zebrafish m2de1 element in its 
reverse orientation.  A total of 16 embryos were imaged for EGFP expression at 48 hours 
post fertilization using the Zeiss LSM 510 Confocal Microscope after injection with the pDr-
m2de1R-cfos-EGFP construct.  Nine of these injected embryos displayed reporter gene 
expression.  As expected, EGFP expression was seen in anterior regions of the zebrafish 
embryos (Fig. 23) mirroring endogenous meis2a expression (Fig. 20).  More specifically, 
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reporter gene expression appears to be located within the midbrain, portions of the hindbrain, 
as well as the tectum (Fig. 23).  Little to no EGFP expression was seen in the developing 
eyes of the embryos (Fig. 23).   
 
 
Fig. 23.  pDr-m2de1R-cfos-EGFP reporter gene expression.  The images above depict EGFP 
expression localization in 48 hours post fertilization zebrafish embryos previously injected 
with pDr-m2de1R-cfos-EGFP construct.  Two orientations were utilized for viewing the 
embryos:  a dorsal (top-down) orientation in which the upper portion of the zebrafish head 
was visible (A), and a sagittal orientation in which the lateral areas of the zebrafish head 
could be analyzed (B).  The expression of EGFP was found throughout the midbrain (blue 
arrow), portions of the hindbrain (red arrow), and tectum (yellow arrow). 
 
Expression Directed by the Mouse m2de1 Element 
The pMm-m2de1F-cfos-EGFP construct contains the mouse m2de1 element in its 
forward orientation.  A total of 14 embryos were imaged for EGFP expression at 48 hours 
post fertilization using the Zeiss LSM 510 Confocal Microscope after injection with the 
pMm-m2de1F-cfos-EGFP construct.  All 14 of these injected embryos displayed reporter 
gene expression.  As expected, EGFP expression was seen in anterior regions of the zebrafish 
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embryos (Fig. 24) mirroring endogenous meis2a expression (Fig. 20).  More specifically, 
reporter gene expression appears to be located within the midbrain, portions of the hindbrain, 
as well as the tectum (Fig. 24).  However, the sagittal orientation of the embryo revealed 
some novel EGFP localizations within neurons that appear to be associated with the otic cup 
and developing ear (Fig. 24B).  As seen before, little to no EGFP expression was seen in the 
developing eyes of the embryos (Fig. 24).   
 
 
Fig. 24.  pMm-m2de1F-cfos-EGFP reporter gene expression.  The images above depict 
EGFP expression localization in 48 hours post fertilization zebrafish embryos previously 
injected with pMm-m2de1F-cfos-EGFP construct.  Two orientations were utilized for 
viewing the embryos:  a dorsal (top-down) orientation in which the upper portion of the 
zebrafish head was visible (A), and a sagittal orientation in which the lateral areas of the 
zebrafish head could be analyzed (B).  The expression of EGFP was found throughout the 
midbrain (blue arrow), portions of the hindbrain (red arrow), and tectum (yellow arrow).  
Additionally, neurons associated with the developing ear appear to possess EGFP expression 
(orange arrows). 
 
The pMm-m2de1R-cfos-EGFP construct contains the mouse m2de1 element in its 
reverse orientation.  A total of 13 embryos were imaged for EGFP expression at 48 hours 
post fertilization using the Zeiss LSM 510 Confocal Microscope after injection with the 
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pMm-m2de1R-cfos-EGFP construct.  Twelve of these 13 injected embryos displayed 
reporter gene expression.  As expected, EGFP expression was seen in anterior regions of the 
zebrafish embryos (Fig. 25) mirroring endogenous meis2a expression (Fig. 20).  More 
specifically, reporter gene expression appears to be located within the midbrain, portions of 
the hindbrain, as well as the tectum (Fig. 25).  However, unlike the pMm-m2de1F-cfos-
EGFP, the sagittal orientation of the embryo did not reveal any novel EGFP localizations, but 
instead directed EGFP expression in regions highly similar to those directed by the zebrafish 
m2de1 elements (Fig. 25B).  Therefore, it appears as if a simple orientation change of the 
element may have been enough to alter reporter gene expression, although other explanations 
are feasible.  As seen before, little to no EGFP expression was seen in the developing eyes of 
the embryos (Fig. 25).   
 
 
Fig. 25.  pMm-m2de1R-cfos-EGFP reporter gene expression.  The images above depict 
EGFP expression localization in 48 hours post fertilization zebrafish embryos previously 
injected with pMm-m2de1R-cfos-EGFP construct.  Two orientations were utilized for 
viewing the embryos:  a dorsal (top-down) orientation in which the upper portion of the 
zebrafish head was visible (A), and a sagittal orientation in which the lateral areas of the 
zebrafish head could be analyzed (B).  The expression of EGFP was found throughout the 
midbrain (blue arrow), portions of the hindbrain (red arrow), and tectum (yellow arrow). 
A B 
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Mutation of the Potential Hox Binding Site Alters Expression 
The pDr-m2de1F-mut-cfos-EGFP construct contains the zebrafish m2de1 element in 
forward orientation but with a potential binding site sequence mutation.  A total of six 
embryos were imaged for EGFP expression using the Zeiss LSM 510 Confocal Microscope 
after injection with the pDr-m2de1F-mut-cfos-EGFP construct at 48 hours post fertilization.  
In all, four of the embryos displayed reporter gene expression.  Also, 16 embryos were 
imaged for EGFP expression using the Zeiss LSM 510 Confocal Microscope after injection 
with the pDr-m2de1F-mut-cfos-EGFP construct at 54 hours post fertilization.  The 54 hours 
post fertilization time frame was not randomly chose but was the exact time that Parker et al. 
chose to view embryos that had been injected with their respective element.  Seven of these 
16 injected embryos displayed reporter gene expression.   
By mutating the single putative Hox binding site, the expression pattern of EGFP was 
dramatically altered (Fig. 26).  This altered expression does not resemble the expression 
patterns seen by Parker et al. at 54 hours post fertilization, but instead novel localizations 
were identified (Fig. 26C-D).  Although reporter gene expression is still seen within the 
developing midbrain and hindbrain, EGFP appears to have become much more localized to 
specific neurons within the developing brain of the zebrafish embryos (Fig. 26).  The 48 
hours post fertilization embryos and the 54 hours post fertilization embryos possess varying 
EGFP expression patterns as well (Fig. 26).  At 48 hours post fertilization, EGFP appears in a 
clump of neurons right behind the eye of the embryo, while at 54 hours post fertilization this 
clump is not present (Fig. 26B and Fig. 26D).  Instead, EGFP appears strongly in the 
forebrain of the embryo at 54 hours post fertilization (Fig. 26D).  Forebrain expression is 
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seen at 48 hours post fertilization in embryos injected with the pDr-m2de1F-mut-cfos-EGFP 
construct but its expression is very faint (Fig. 26B). 
           
 
 
 
Fig. 26.  pDr-m2de1F-mut-cfos-EGFP reporter gene expression.  The images above depict 
EGFP expression localization in 48 hours post fertilization zebrafish embryos (A-B) and in 
54 hours post fertilization zebrafish embryos (C-D) previously injected with pDr-m2de1F-
mut-cfos-EGFP construct.  Two orientations were utilized for viewing the embryos:  a dorsal 
(top-down) orientation in which the upper portion of the zebrafish head was visible (A and 
C), and a sagittal orientation in which the lateral areas of the zebrafish head could be 
analyzed (B and D).  The expression of EGFP was found throughout the midbrain (blue 
Dr-m2de1F-mut Dr-m2de1F-mut 
A B 
C D 
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arrow) and portions of the hindbrain (red arrow).  At 48 hours post fertilization, EGFP 
expression is seen in an unidentified clump right behind the eye of the zebrafish (yellow 
arrow) and faintly in the forebrain (purple arrow).  At 54 hours post fertilization, EGFP 
expression is seen prominently in the forebrain of the zebrafish (orange arrow). 
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DISCUSSION 
To date, much has been revealed concerning the diverse roles that the Meis genes 
play in embryonic development, and the expression patterns of the Meis genes have been 
well documented; however, while the developmental importance of the Meis genes has been 
addressed, very little is known about the regulation of their expression.  The meis2a gene in 
zebrafish is no exception.  Of recent interest concerning transcriptional regulation of 
developmentally significant genes are cis-regulatory elements (Alberts, 2008; Kikuta et al., 
2007b; Navratilova and Becker, 2009).  Cis-regulatory elements are sequences of DNA that, 
while not expressed, help to direct the expression of a gene by serving as additional binding 
sites for transcription related proteins (Kikuta et al., 2007b; Woolfe et al., 2005).  In this 
study, we have identified a cis-regulatory element that directs the expression of the meis2a 
gene in Danio rerio. 
Due to their importance in gene expression and their relation with developmental 
genes, the same cis-regulatory elements are often found in widely divergent organisms with 
remarkably similar sequences (Engstrom et al., 2007; Navratilova and Becker, 2009).  As a 
result of this conservation, phylogenetic footprinting is often used to find potential cis-
regulatory elements (Fisher et al., 2006; Kikuta et al., 2007a; Kikuta et al., 2007b; Woolfe et 
al., 2005).  Previously in the Zerucha lab, Phylogenetic footprinting of the human MEIS2 
sequence resulted in the detection of 4 HCNEs that have been named m2de (1-4) (Wellington 
and Zerucha, unpublished).  All four of the m2de1 elements possess the characteristics that 
would be expected of functional cis-regulatory elements.  First, the four elements are highly 
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conserved across the variety of organisms analyzed and in some extended areas even show 
100% sequence conservation suggesting functional significance.  Secondly, binding sites for 
transcriptional proteins, most notably Hox, Pbx and Meis factors, have been identified within 
the four m2de1 elements.  The presence of binding sites indicates the potential for the four 
elements to recruit additional, yet necessary proteins for the direction of gene expression.  
Lastly, the elements were discovered in relative close proximity to MEIS2; a vital 
developmental gene.  Only one of the identified m2de1 elements was found to be present in 
zebrafish; the m2de1 element (Wellington and Zerucha, unpublished).  The m2de1 element 
possesses approximately 450 nucleotides that are conserved while 260 of those nucleotides 
appear to be highly conserved showing 68% sequence conservation between humans and 
zebrafish.  Analysis of adjacent regions revealed that an additional 325 nucleotides may 
possess cis-regulatory function as well, in turn contributing to the overall meis2a expression 
pattern.  
However, just identifying HCNEs does not guarantee that the conserved sequences 
possess actual cis-regulatory function.  A proven method in which to test for such 
functionality  is to couple the HCNE with a minimal promoter and a reporter gene creating an 
expression cassette, placing the cassette into the genome of developing embryos, and then 
analyzing the organism for HCNE driven reporter gene expression (Fisher et al., 2006; Li et 
al., 2010; Pauls et al., 2012; Zerucha et al., 2000).  The minimal promoter serves to drive 
reporter gene expression only if the adjacent cis-regulatory element is bound by transcription 
factors (Fisher et al., 2006; Li et al., 2010).  As stated previously, if the HCNE functions as a 
cis-regulatory element, the spatiotemporal characteristics of the reporter gene expression 
patterns should resemble the expression of the gene the HCNE works to direct (Fisher et al., 
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2006; Li et al., 2010).  In order to create transgenic reporter constructs containing the 
expression cassettes, a series of step-wise procedures were carried out in order to build the 
constructs.  In total, four unmutated transgenic reporter constructs were developed:  construct 
with the zebrafish m2de1 element in forward orientation (pDr-m2de1F-cfos-EGFP), 
construct with the zebrafish m2de1 element in reverse orientation (pDr-m2de1R-cfos-EGFP), 
construct with mouse m2de1 element in forward orientation (pMm-m2de1F-cfos-EGFP), and 
construct with mouse m2de1 element in reverse orientation (pMm-m2de1R-cfos-EGFP). 
In order to determine if in fact the m2de1 element remained unaltered throughout the 
transgenic reporter construct construction process, the zebrafish m2de1 element amplified 
from the zebrafish genomic DNA, the pCR®2.1-TOPO® cloning vector containing the 
zebrafish m2de1 element, and the pDr-m2de1F-cfos-EGFP construct were sent off for Sanger 
DNA sequencing.  The sequencing analysis of the three constructs showed that two 
nucleotides within the m2de1 element differ from the sequence identified in the published 
zebrafish genome.  In the first case, a cytosine was mislabeled as a thymine and in the second 
case, a guanine was mislabeled as an adenine.  All three of the sequencing analyses support 
this finding as all three sequenced constructs contained nucleotide variances in the same 
positions within the m2de1 sequence, and all three constructs had the same nucleotides in 
those locations also.  It is possible this is due to differences between the individual fish used 
for the zebrafish genome project and for our isolation of the m2de1 region, or perhaps due to 
errors in the zebrafish genome sequence.  As these variant nucleotides were determined to 
not be within any obvious transcription factor binding sites, they should not have been 
detrimental to the project.  Nonetheless, such a finding is rather interesting and warrants 
further study.   
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Research published during the construction of the aforementioned unmutated 
transgenic reporter constructs revealed that a cis-regulatory element containing an almost 
identical sequence to the m2de1 element directed reporter gene expression in a different way 
than the pDr-m2de1F-cfos-EGFP construct did (Parker et al., 2011).  The element described 
in this published study was identical to m2de1 except that the element lacked 17 additional 
base pairs, including a Hox binding site (TAAT) that was incorporated into the m2de1 
element.  In order to determine if this 17 base pair region was responsible for the differences 
observed between our experiments and those described in the Parker paper, I mutated the 
potential Hox binding site within the m2de1 element that was not present in the Parker 
element.  The final construct contained the mutated zebrafish m2de1 element in forward 
orientation (pDr-m2de1F-mut-cfos-EGFP).  After the pDr-m2de1F-mut-cfos-EGFP reporter 
construct was made, restriction with ClaI resulted in a plasmid band of 6700 base pairs and a 
larger than expected insert band of 1600 base pairs.  Sequencing of the plasmid established 
that the TAATG sequence containing the Hox binding site had indeed been altered to the 
sequence TCGAT and that the insert was correct.  The incorrect size of the smaller band is 
puzzling as the total size of the intact construct itself should only be 7941 base pairs long, not 
8300 base pairs long as the restriction analysis suggests.  One possible explanation for this 
discrepancy is that the ClaI enzyme remained attached to the fragment during gel 
electrophoresis and resulted in the size ambiguity.       
Microinjections were subsequently performed to determine if the m2de1 element is 
able to direct expression of EGFP in a manner that is consistent with the known expression 
pattern of Meis2.  After microinjection into the zebrafish embryos yolk, the pCS2FA Tol2 
Transposase mRNA was translated into transposase protein that subsequently recognized the 
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Tol2 recombination sites flanking the m2de1 expression cassette.  The m2de1 element was 
cleaved from the reporter construct by the Tol2 transposase and relocated into the embryos 
genome where cis-regulatory functionality would be tested.   
The analysis of the transgenic embryos revealed that the m2de1 element does in fact 
drive expression in a manner consistent with the meis2a gene in zebrafish and potentially the 
Meis2 gene in mouse.  In total, all five experimental constructs as well as a positive control 
construct were injected and analyzed:  positive control construct (pDest-Sox10-mCherry-
Tol2CG2; graciously provided by Dr. Chi-Bin Chien), construct with the zebrafish m2de1 
element in forward orientation (pDr-m2de1F-cfos-EGFP), construct with the zebrafish 
m2de1 element in reverse orientation (pDr-m2de1R-cfos-EGFP), construct with mouse 
m2de1 element in forward orientation (pMm-m2de1F-cfos-EGFP), construct with mouse 
m2de1 element in reverse orientation (pMm-m2de1R-cfos-EGFP), and the construct 
containing the zebrafish m2de1 element in forward orientation but with a potential Hox 
binding site sequence mutation (pDr-m2de1F-mut-cfos-EGFP).  I decided to analyze the 
transgenic embryos at varying time frames post fertilization as m2de1 is a novel, putative 
enhancer.  Although m2de1 was predicted to drive meis2a expression at 24 hours post 
fertilization due to the expression patterns previously observed, enhancers are known to vary 
in function based on their cellular context and molecular environment and the transcriptional 
proteins that bind to them (Carpenter, 2010; Woolfe et al., 2005).  Furthermore, many 
developmentally important genes utilize multiple enhancers to drive their expression (Kikuta 
et al., 2007; Navratilova and Becker, 2009).  Taking these two ideas into account, it is easy to 
see that by testing the putative enhancers out of their natural cellular and molecular 
“environment,” it is possible to have expression differ spatially and temporally from 
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endogenous expression (Woolfe et al., 2005).  EGFP expression was soon seen at 48 hours 
post fertilization, a rather unexpected discovery.   
The expression patterns of the EGFP resulting from the injection of the unmutated 
constructs were extremely similar to the meis2a expression patterns.  This not only shows 
that the m2de1 element has cis-regulatory function, but reveals that the m2de1 element may 
potentially be involved in the direction of meis2a expression.  Reporter gene expression was 
seen confined to anterior regions, most notably in the midbrain and parts of the hindbrain, but 
not directly within the developing eye or retina where meis2a is known to be expressed 
(Carpenter, 2010).  Expression appears to be rather non-localized and spread out through the 
anterior areas. Although expression was diffuse throughout neurons in these regions and not 
necessarily localized to any particular identifiable structure, expression was seen within the 
tectum corroborating with the meis2a expression profile (Carpenter, 2010).  This is a rather 
striking discovery because, as stated earlier, Meis2 is believed to play a role in eye 
development.  The tectum is responsible for visual reflexes and processing; therefore m2de1 
seems to at least be partially responsible for the expression of Meis2 within the tectum, 
implicating m2de1 with the Meis2 gene’s association with vision.   
Only one of the unmutated constructs resulted in a divergent EGFP expression 
profile; the pMm-m2de1F-cfos-EGFP construct.  For some reason, this element when 
injected in zebrafish drives EGFP expression within neurons associated with the otic cup and 
the developing ear.  Conversely, pMm-m2de1R-cfos-EGFP drove EGFP expression in the 
same way that pDr-m2de1F-cfos-EGFP and pDr-m2de1R-cfos-EGFP did.  A logical 
explanation for this anomaly could be that the expression cassette within the pMm-m2de1F-
cfos-EGFP construct was inserted nearby other cis-regulatory elements that direct expression 
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of genes expressed near the zebrafish ear.  These cis-regulatory elements could have 
sufficiently mobilized the minimal promoter resulting in EGFP expression in a rather unusual 
location.  Regardless, the fact that the mouse element in the pMm-m2de1R-cfos-EGFP 
construct drove EGFP expression in the same way as the zebrafish m2de1 element after 
insertion into the zebrafish genome further shows that the m2de1 element functions as a cis-
regulatory element.  Such expression pattern similarity indicates conservation in function 
between the elements from zebrafish and mouse strengthening the claim that the m2de1 
element has resisted evolutionary change due to inherent developmental importance as a cis-
regulatory element.   
The mutated construct, pDr-m2de1F-mut-cfos-EGFP, resulted in an EGFP expression 
pattern that was dramatically altered.  Oddly, this different expression does not resemble the 
expression patterns seen by Parker et al. as eradicating the additional putative Hox binding 
site should have eradicated any functional differences that potentially exists between the 
m2de1 elements and the elements utilized by Parker and colleagues.  Instead, injection of the 
mutated reporter construct resulted in the localization of EGFP in previously unseen areas.  
In fact, the mutated m2de1 element appears to have directed the EGFP expression to more 
specific neurons and locations within the brain of the zebrafish embryos, although this 
localized reporter gene expression is still seen within the developing midbrain and hindbrain.  
The 48 hours and the 54 hours post fertilization zebrafish embryos have different EGFP 
expression patterns also.  For the embryos injected with the pDr-m2de1F-mut-cfos-EGFP 
construct, many were viewed at 54 hours post fertilization for comparison purposes because 
that was the time in development that Parker and colleagues viewed their transgenic embryos 
(Parker et al., 2011).  At 48 hours post fertilization, EGFP is seen in a cluster of neurons 
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directly posterior from the eye of the embryo, while at 54 hours post fertilization this mass is 
not seen.  The EGFP also appears intensely in the forebrain of the embryo at 54 hours post 
fertilization, while in the 48 hours post fertilization embryos injected with the pDr-m2de1F-
mut-cfos-EGFP construct, EGFP expression is very faint in the forebrain.  Therefore, it is 
readily apparent how the eradication of a single binding site can completely alter the 
expression profiles associated with a specific gene.  These differential expression patterns 
stemming from the mutation could be the result of numerous potential dynamics.  One of the 
most probable explanations is that by eradicating the Hox binding site, we could have 
inadvertently removed a repressor site within the m2de1 element.  This could in turn allow 
for expression in locales such as the forebrain and in the area posterior to the eye where 
expression is normally repressed by the cis-regulatory mechanism.  Another explanation for 
the divergent expression patterns that resulted from injection of the mutated transgenic 
reporter construct is that we could have introduced another binding site in place of the Hox 
binding site.  Although no literature exists stating that the TCGAT sequence serves as a 
transcription factor binding site, there exists an outside chance that it actually does.  If the 
sequence is a binding site, the binding of novel proteins to the m2de1 element could alter the 
expression driven by the cis-regulatory element explaining the unusual EGFP localizations. 
In conclusion, data resulting from this study concerning the functionality of a 
previously unidentified putative enhancer element indicates that m2de1 is a putative cis-
regulatory element, potentially working to direct the expression of meis2a in zebrafish.  
However, the m2de1 element by itself and without its correct molecular surroundings is 
unable to recapitulate the meis2a expression profile in its entirety and it remains to be seen if 
a direct correlation actually exists between the m2de1 element and meis2a regulation.  Taken 
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together, the work done for this study helped to characterize a novel cis-regulatory element 
possibly involved in the regulation of Meis expression. 
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